Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »


Stryker Enters Twenty-year Partnership with Indo UK Institute of Health's Medicity Program to Provide More Accessible Healthcare Solutions in India BY ANDREW VAHRADIAN, NOVEMBER 29, 2016

Stryker entered a twenty-year collaboration partnership agreement with Indo UK Institute of Health's Medicity Program (IUIH) to develop solutions to enhance the quality of healthcare in the country of India and to make such services more accessible and affordable for... more

Medtronic Launches its Orthopedic Solutions Initiative BY ANDREW VAHRADIAN, NOVEMBER 14, 2016

Medtronic launched its Medtronic Orthopedic Solutions initiative, a comprehensive offering that seeks to improve patient outcomes and reduce costs for hospitals/patients across an entire episode of care of total joint replacement procedures. The company has developed this new offering in... more

Amplitude Surgical Acquires the Remaining 40% Stake in Unimplant BY ANDREW VAHRADIAN, SEPTEMBER 28, 2016

Amplitude Surgical exercised the company's call option to acquire the remaining (40%) minority interests in its Brazilian subsidiary, Unimplant, for approximately €4.1 million ($4.6 million). Amplitude develops medical devices for lower-limb orthopedic procedures in the hip, knee and extremities segments,... more

GE to Acquire Both Arcam AB and SLM Solutions for an Aggregate $1.4B BY ANDREW VAHRADIAN, SEPTEMBER 19, 2016

GE entered into agreements to acquire Arcam AB and SLM Solutions Group, two suppliers of additive manufacturing equipment, for approximately $1.4 billion in aggregate. Both transactions will be structured as a public tender offer for all of the outstanding shares... more

Stryker to Acquire Ivy Sports Medicine BY ANDREW VAHRADIAN, SEPTEMBER 7, 2016

Stryker's Endoscopy division entered into an agreement to acquire Ivy Sports Medicine, LLC, a company that develops minimally invasive meniscal repair solutions. Under the terms of the transaction, Stryker acquires Ivy's product portfolio which consists of the company's Collagen Meniscus... more

Zimmer Biomet to Acquire CD Diagnostics BY ANDREW VAHRADIAN, AUGUST 15, 2016

Zimmer Biomet entered into an agreement to acquire CD Diagnostics, a U.S.-based fully-integrated diagnostics company. The financial terms of the deal were not disclosed. CD Diagnostics develops immunoassays and biomarker testing products that analyze various clinical conditions in a person's... more

Smith & Nephew’s NAVIO Surgical System Achieves Robotics-assisted Milestone for Total Knee Replacement Surgery BY EDITOR, JULY 28, 2016

Smith & Nephew (NYSE: SNN; LSE:SN), the global medical technology business, announced the first surgical case of its robotics-assisted total knee replacement procedure. The new approach, which recently received 510(k) clearance from the US Food and Drug Administration, uses the... more

Wright Medical to Sell Legacy Tornier Large Joint Business to Corin Orthopaedics for $33M BY ANDREW VAHRADIAN, JULY 11, 2016

Wright Medical entered into an agreement to divest its hip and knee (large joint) businesses to Corin Orthopaedics for a purchase price of €29.7 million ($33 million), which values the portfolio at 0.9x 2016E revenues of $37 million and 6.0x... more

Amedica Prices $11M Public Offering BY ANDREW VAHRADIAN, JULY 5, 2016

Amedica priced a public offering of shares for gross proceeds of $11 million. Under the terms of the offering, the company will sell Class A Units at a public offering price of $1.00 per unit. Each Class A Unit consists... more

Medtronic to Acquire Responsive Orthopedics BY ANDREW VAHRADIAN, JUNE 7, 2016

Medtronic announced the acquisition of Responsive Orthopedics, a developer of low-cost primary joint replacement systems. In order to address the various macroeconomic changes taking place in the U.S. health care system, Responsive Orthopedics has focused on developing a platform of... more

RoundTable Healthcare Partners to Acquire Symmetry Surgical for $129M BY ANDREW VAHRADIAN, MAY 9, 2016

RoundTable Healthcare Partners, a healthcare focused private equity firm, entered into an agreement to acquire Symmetry Surgical for an enterprise value of $129.5 million, valuing the business at 1.5x LTM revenues of $85.0 million, or 15.5x LTM EBITDA of $8.4... more

Stryker to Acquire Stanmore Implants for $52M BY ANDREW VAHRADIAN, MAY 1, 2016

Stryker entered into an agreement to acquire Stanmore Implants Worldwide Limited in an all cash transaction for £35.6 million ($51.9 million). Stanmore is an England-based developer of orthopedic implants and solutions for orthopedic adult and juvenile oncology, and complex primary... more

Zimmer Biomet to Acquire Cayenne Medical BY ANDREW VAHRADIAN, APRIL 25, 2016

Zimmer Biomet entered into an agreement to acquire Cayenne Medical, a company in the soft tissue repair and reconstruction segment of the sports medicine market. The financial terms of the transaction were not disclosed. Cayenne develops soft tissue reconstruction solutions... more

FDA's Orthopaedic and Rehabilitation Devices Panel Recommends Approval for Cartiva's SCI Device BY ANDREW VAHRADIAN, APRIL 21, 2016

Cartiva announced that the FDA's Orthopaedic and Rehabilitation Devices Panel voted in favor of the company's Premarket Approval application (PMA) of its Cartiva Synthetic Cartilage Implant (SCI) for the treatment of osteoarthritis (OA) at the base of the great toe.... more

Smith & Nephew to Launch Blue Belt Technologies' Navio System in India BY ANDREW VAHRADIAN, APRIL 6, 2016

Smith & Nephew announced plans to launch Blue Belt Technologies' Navio surgical robotic system, a recent acquisition, in the Indian marketplace. Blue Belt's Navio system provides robotics-assistance in unicondylar (uni) or partial knee replacement surgical procedures via CT-free navigation software... more

The Medical Center at Loma Linda University Reduces Orthopedic Procedure Costs by Instituting a Rep-less Sales Model BY ANDREW VAHRADIAN, JANUARY 28, 2016

As a broader effort to cut medical-device costs and improve clinical quality through greater standardization of devices used in surgical procedures, a small number of hospitals around the country are collaborating with manufacturers to train their own employees to provide... more

Smith & Nephew to Acquire BST-CarGel Product from Piramal Healthcare BY ANDREW VAHRADIAN, JANUARY 12, 2016

Smith & Nephew entered into an agreement to acquire all product and intellectual property assets of Piramal Healthcare (Canada) Limited's BST-CarGel product, a first-line cartilage repair product utilized in conjunction with microfracture and other bone marrow stimulation techniques for the... more

NuVasive Enters into an Agreement to Acquire Ellipse Technologies BY ANDREW VAHRADIAN, JANUARY 6, 2016

NuVasive entered into a definitive agreement to acquire Ellipse Technologies, Inc., a medical device company focused on progressing procedural solutions for complex skeletal deformity with magnetically adjustable implant systems, for an enterprise value of up to $465 million, or 11.6x... more

Smith & Nephew Completes Acquisition of Surgical Robotics Business Blue Belt Technologies BY EDITOR, JANUARY 5, 2016

Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announced it has completed the acquisition of Blue Belt Holdings, Inc. (“Blue Belt Technologies”), securing a leading position in the fast-growing area of orthopaedic robotics-assisted surgery. Blue Belt Technologies’ Navio... more

KFx Sells its AppianFx System to CONMED BY ANDREW VAHRADIAN, DECEMBER 9, 2015

KFx completed the sale of its AppianFx product, a soft tissue fixation system, to CONMED Corporation. AppianFx is an all-inside, dual expanding, PEEK Femoral anchor system that is implanted arthroscopically. The company received 510(k) clearance from the FDA for AppianFx... more

CMS Finalizes New Bundled Payment Initiative for Hip/Knee Replacements BY ANDREW VAHRADIAN, NOVEMBER 19, 2015

The Centers for Medicare & Medicaid Services (CMS) finalized its Comprehensive Care for Joint Replacement (CJR) payment model which will hold hospitals accountable for the quality of care they deliver to Medicare fee-for-service beneficiaries for hip and knee replacements and/or... more

Silver Lake Medical Center and Blue Belt Technologies Announce First Hospital in Los Angeles to Implement CT-free Robotic Orthopedic Surgery BY EDITOR, NOVEMBER 16, 2015

Silver Lake Medical Center and Blue Belt Technologies announced the completion of the first procedure with the Navio orthopedic surgical system to help surgeons perform precise and accurate partial knee replacement surgeries. The Navio system helps Silver Lake Medical Center... more

Ivy Sports Medicine Announces the First U.S. Implantation of its Collagen Meniscus Implant BY ANDREW VAHRADIAN, NOVEMBER 12, 2015

Ivy Sports Medicine announced the first U.S. implantation of its Collagen Meniscus Implant (CMI), a biocompatible scaffold made of highly purified collagen that can be used to reinforce and repair a meniscus defect following partial meniscectomy or for irreparable meniscus... more

Smith & Nephew Makes Strategic Investment in Surgical Robotics with Acquisition of Blue Belt Technologies BY EDITOR, OCTOBER 29, 2015

Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces it has agreed to acquire Blue Belt Holdings, Inc. (“Blue Belt Technologies”) for $275 million, securing a leading position in the fast-growing area of orthopaedic robotics-assisted surgery. “Our experience... more

Lima Corporate to Acquire Zimmer Knee and Elbow Line Rights in Japan BY ANDREW VAHRADIAN, SEPTEMBER 29, 2015

Lima Corporate entered into an agreement with Zimmer Biomet to acquire Zimmer's Unicompartmental High Flex Knee (ZUK) and the Discovery Elbow systems for the Japanese market. This transaction is in accordance with the conditional clearance from the Japan Fair Trade... more

Orchid Orthopedic Announces Acquisition of Alhenia AG BY ANDREW VAHRADIAN, SEPTEMBER 14, 2015

Orchid Orthopedic entered into a definitive agreement to acquire Alhenia AG, a Swiss-based provider of machined and coated orthopedic implants. Alhenia provides machined components, bio-compatible coatings and finishing services to device manufacturers in the hip, knee, spine and extremities markets... more

Blue Belt Technologies Announces First Navio Case Utilizing Smith & Nephew’s ZUK Unicompartmental Knee BY EDITOR, SEPTEMBER 9, 2015

Blue Belt Technologies, a medical device company specializing in advanced technology solutions for orthopedic surgery, announced the first Navio-assisted partial knee replacement performed utilizing Smith & Nephew’s ZUK unicompartmental (uni) knee. The case was performed by Dr. Michael Miranda, a... more

Blue Belt Technologies Announces Support for Smith & Nephew’s ZUK Knee on the Navio Surgical System BY EDITOR, SEPTEMBER 8, 2015

Blue Belt Technologies, a medical device company specializing in advanced technology solutions for orthopedic surgery, announced commercial support for Smith & Nephew’s ZUK unicompartmental (uni) knee on Blue Belt’s Navio robotics-assisted system. The ZUK is a clinically established uni knee... more

Researchers Utilize Nanotechnology to Develop an Antibiotic Delivery Approach to Protect Orthopedic and Dental Implants from Infection BY ANDREW VAHRADIAN, JULY 23, 2015

Researchers at the University of Sheffield demonstrated that the application of small quantities of antibiotics to the surface between the polymer layers of orthopedic and dental implants can help prevent bacteria and other harmful microorganisms from attaching, and subsequently growing... more


ConforMIS priced its initial public offering (IPO), by offering 9.0 million shares of common stock at a price of $15 a share, raising total proceeds of $135 million. This equates to an enterprise value of approximately $632 million, valuing the... more

Zimmer Receives FTC Clearance for its Acquisition of Biomet and Divests Certain Product Lines BY ANDREW VAHRADIAN, JUNE 24, 2015

Zimmer received clearance from the U.S. Federal Trade Commission (FTC) regarding its cash/stock acquisition of Biomet currently valued at approximately $14.0 billion. This effectively completes the transaction which was initially announced in April 2014. The transaction combines two product portfolios... more

ConforMIS Proposes $173M IPO BY ANDREW VAHRADIAN, MAY 22, 2015

ConforMIS, Inc. filed an S-1 to raise up to $172.5 million through an initial public offering (IPO) of common shares. The price range and number of shares to be sold in the offering has not yet been determined. The company... more

Lima Corporate to Acquire Zimmer and Biomet Reconstruction Lines BY ANDREW VAHRADIAN, APRIL 16, 2015

Lima Corporate entered into an agreement to acquire Zimmer's Unicompartmental High Flex Knee (ZUK) and Biomet's Discovery Elbow systems within the European Economic Area (EEA) and Switzerland, as well as Biomet's Vanguard Complete Knee System in Denmark and Sweden. This... more

Zimmer Receives Conditional Clearance from the European Commission to Acquire Biomet BY ANDREW VAHRADIAN, MARCH 30, 2015

The European Commission (EC) cleared Zimmer's proposed $13.4 billion cash/stock acquisition of Biomet, on the condition that the combined company sell three of its European businesses. Under the terms of the conditional clearance by the EC, Zimmer will need to... more

Ferring Pharmaceuticals Acquires BioSurface Engineering Technologies BY ANDREW VAHRADIAN, FEBRUARY 19, 2015

Ferring Pharmaceuticals entered into an agreement to acquire the assets of BioSurface Engineering Technologies Inc. (BioSET), a developer of biomimetic growth factor peptide medical devices intended to regenerate bone and improve soft tissue repair. Under the terms of the transaction,... more

Researchers Develop Rheumatoid Arthritis Treatment that Eliminates the Need for Drugs BY ANDREW VAHRADIAN, JANUARY 9, 2015

Researchers at the at the Academic Medical Centre in Amsterdam are assessing a new treatment methodology for rheumatoid arthritis that can eliminate the need for patients to take drugs. The novel treatment involves a pacemaker-style bioelectronics device that is implanted... more

Researchers Develop New Method to Regenerate the Human Meniscus BY ANDREW VAHRADIAN, DECEMBER 12, 2014

A team of researchers at Columbia University Medical Center describe a newly developed methodology in a paper published in Science Translational Medicine, to replace the human meniscus utilizing a personalized 3-D printed implant (scaffold) infused with human growth factors. Damaged... more

Histogenics Prices IPO BY ANDREW VAHRADIAN, DECEMBER 4, 2014

Histogenics priced its initial public offering (IPO) of 5.9 million shares of common stock at a price of $11.00 per share, raising total proceeds of $65 million. This equates to an enterprise value of approximately $139 million. The final terms... more

Corin Group to Acquire Optimized Ortho BY ANDREW VAHRADIAN, NOVEMBER 26, 2014

Corin Group entered into an agreement to acquire Optimized Ortho, an Australian orthopedics company that provides various technologies for improving orthopedic implant component positioning for total hip and knee arthroplasty. Optimized Ortho's key technology is its Optimized Positioning System (OPS),... more

Histogenics Proposes Terms for IPO BY ANDREW VAHRADIAN, NOVEMBER 18, 2014

Histogenics filed to raise between $56 million and $64 million through a previously announced initial public offering (IPO), by offering 4.3 million shares of common stock at a proposed price range of $13-$15 a share. At the midpoint of the... more

Histogenics Proposes $65M IPO BY ANDREW VAHRADIAN, OCTOBER 8, 2014

Histogenics Corporation filed an S-1 to raise up to $65 million through an initial public offering (IPO) of common shares. The price range and number of shares to be sold in the offering has not yet been determined. Histogenics' principal... more

Amedica Appoints New President & CEO BY ANDREW VAHRADIAN, OCTOBER 6, 2014

Amedica Corporation announced the appointment of Dr. Sonny Bal as the company's President and Chief Executive Officer. Dr. Bal has served as a member of Amedica's Board since February 2012, and as its Chairman since August 20th, 2014. He succeeds... more

Blackstone to Acquire Stake in Xinrong Best Medical Instrument for a Reported $100M BY ANDREW VAHRADIAN, SEPTEMBER 23, 2014

The Blackstone Group entered into an agreement to acquire an unspecified stake in Xinrong Best Medical Instrument Co., a Chinese-based developer of orthopedic implants with Trauma, Spine and Joint applications, for a reported $100 million. Xinrong is planning to target... more

DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA HP Partial Knee on the Navio Surgical System BY EDITOR, SEPTEMBER 17, 2014

DePuy Synthes, the world's largest provider of orthopaedic and neurological solutions, announced today a worldwide commercial agreement with Blue Belt Technologies, a global medical technology company specializing in enabling technologies for orthopaedic surgery. The agreement will enable orthopaedic surgeons to... more

Researchers Reveal Nasal Septum Cells’ Ability to Treat Articular Cartilage Defects BY ANDREW VAHRADIAN, SEPTEMBER 12, 2014

A team of researchers at the University and the University Hospital of Basel, revealed that cartilage cells extracted from the nasal septum, called nasal chondrocytes, not only are able to adapt to the environment of the knee joint, but also... more

Smith & Nephew Unveils New Discounted, Hospital-focused Sales Model BY ANDREW VAHRADIAN, AUGUST 14, 2014

Smith & Nephew unveiled a new hospital-focused sales model that will offer two of the company's primary hip and knee implants through multiyear contracts at an approximate discounted rate of one-third.
Pages-from-smith_nephew_q2_2014_results_presentation.png more

Blue Belt Technologies Announces 500th Navio Assisted Partial Knee Replacement Surgery BY EDITOR, AUGUST 8, 2014

Blue Belt Technologies announces that on August 5th Dr. Jose Bossolo performed the 500th Navio assisted partial knee replacement surgery, worldwide, at Valley Baptist Medical Center. Valley Baptist is a general care facility in Brownsville, Texas and is part of... more

Blue Belt Technologies Receives 510(k) Clearance for Patellofemoral Joint Replacement Application BY EDITOR, JULY 17, 2014

Blue Belt Technologies has received FDA clearance to market their latest surgical application for the Navio Surgical System, patellofemoral joint (PFJ) replacement surgery. The PFJ application expands the Navio Surgical System’s indications from unicondylar knee replacement to offer the full... more

Blue Belt enters into a commercial agreement with Smith & Nephew to bring the JOURNEY UNI Knee to the Navio Surgical System BY ANDREW VAHRADIAN, JULY 10, 2014

Blue Belt Technologies, a robotics-assisted surgical technology company, today announced a world-wide commercial agreement with Smith & Nephew, a global medical technology business, to support their JOURNEY UNI knee system on Blue Belt’s Navio Surgical System. The Navio system has... more

Johnson & Johnson Plans to Develop a Line of 3-D Printed Reconstructive Implants BY ANDREW VAHRADIAN, JUNE 26, 2014

Last month, Johnson & Johnson (JNJ) announced that the company plans to file for more than 30 major product approvals within its Medical Device & Diagnostic (MD&D) unit by the end of 2016, in order to bolster the segment's overall... more

Microport to Expand Wright Medical Presence BY JOHN MCCORMICK, JUNE 13, 2014

This week, MicroPort, China's largest and most successful private medtech company, announced that it will be investing $100 million over the next 5 years to add to Wright Medical's training capabilities. Having recently closed its acquisition of the Wright Medical... more

Study Links Rise in Total Knee and Hip Replacement Volumes to Obesity, Especially In Younger Adults BY ANDREW VAHRADIAN, JUNE 11, 2014

According to a recent study published in the Journal of Bone and Joint Surgery (JBJS), an increase in the prevalence of overweight and obesity levels in the U.S. accounted for 95% of the higher demand for knee replacements, with younger... more

Medtronic Reported to be Considering an Acquisition of Smith & Nephew BY ANDREW VAHRADIAN, JUNE 5, 2014

Medtronic is reported to be considering an acquisition of Smith & Nephew. Presently, no offer is imminent as Medtronic's bid preparations are believed to be at an early stage. The transaction would impart greater leverage to Medtronic with payor and... more

Johnson & Johnson Plans to Launch 30 New Medical Devices by 2016 BY ANDREW VAHRADIAN, MAY 30, 2014

In the 2013 fiscal year, Johnson & Johnson's Pharmaceutical business grew 12% on a constant currency basis, outstripping the company's Medical Device & Diagnostic (MD&D) segment, which grew at 6%. Therefore, in order to bolster growth to its MD&D unit,... more

Zimmer to Acquire Biomet for $13.4B BY ANDREW VAHRADIAN, APRIL 24, 2014

Zimmer and Biomet announced that each of their respective Boards of Directors have approved a definitive agreement under which Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt,... more

Study Demonstrates Joint Replacement Procedures are "Recession-proof" BY ANDREW VAHRADIAN, APRIL 11, 2014

A new study published in the Journal of Bone and Joint Surgery (JBJS), concluded that the economic recessions experienced in the 21st century up to this point, have not substantially hindered the growth trends for hip and knee arthroplasty in... more


Amedica Corporation priced its initial public offering (IPO) of 3,500,000 shares of common stock at a public offering price of $5.75 per share, raising total proceeds of $20 million. This equates to an enterprise value of approximately $97 million, or... more

Blue Belt Technologies Announces First Navio Unicondylar Knee Replacement Performed in France BY EDITOR, DECEMBER 23, 2013

Blue Belt Technologies announces the first Navio unicondylar knee replacement (UKR) procedures performed in France, completed on September 30th, October 15th and Nov 4th 2013 by Professor Philippe Neyret and Dr. Sébastien Lustig at Hospices Civils de Lyon in France.... more

Blue Belt Technologies in the News BY EDITOR, DECEMBER 13, 2013

We just wanted to highlight recent press coverage of HealthpointCapital's portfolio company Blue Belt Technologies. You can click through the links here to read the company's feature in Outpatient Surgery Magazine, and today's coverage in USA Today's "The Future of... more

Blue Belt Technologies Announces Clinical Milestone with 100th Navio Assisted Partial Knee Replacement BY EDITOR, NOVEMBER 14, 2013

Blue Belt Technologies announces a clinical milestone for the Navio Orthopedic Surgical System with the 100th robotic-control assisted partial knee replacement surgery performed on November 13, 2013. Dr. Jess H. Lonner performed the 100th Navio case, which occurred at the... more

Blue Belt Technologies’ Navio System Assists in Live Partial Knee Surgery Event BY EDITOR, NOVEMBER 14, 2013

Blue Belt Technologies participated in a live surgery day with Dr. Raul Marquez at Cornerstone Regional Hospital, a 14 bed acute care facility in Edinburg, Texas. Dr. Marquez utilized the precision assistance of the Navio surgical system to perform a... more

The FDA Outlines Approach to Personalized Medicine BY ANDREW VAHRADIAN, OCTOBER 31, 2013

It is widely believed that personalized medicine will dramatically change the manner in which medical devices and drugs are developed, tested, and regulated. The FDA believes that with the progression of science, technology and the understanding of the underlying mechanisms... more

Blue Belt Technologies Announces First Sale of the Navio System to a Surgery Center and First Worldwide STRIDE Case BY EDITOR, OCTOBER 15, 2013

Blue Belt Technologies announces the first sale of a Navio orthopedic surgical system to an Ambulatory Surgery Center. The Thomas Jefferson Riverview Surgical Center, at the Navy Yard in Philadelphia, entered into an agreement to purchase Blue Belt’s Navio robotic-controlled... more

European Union Committee Votes in Favor of a Stricter Regulatory Process for Medical Devices BY ANDREW VAHRADIAN, OCTOBER 3, 2013

Members of the European Union parliament's Environment Committee (Committee), voted in favor of a new pre-market authorization (PMA) system that would employ randomized clinical trials for Class III, or high-risk, implantable devices under the oversight of the European Medicines Agency... more

Musculoskeletal News Roundup 26-Sept-13 BY LAUREN UZDIENSKI, SEPTEMBER 26, 2013

SYK to acquire MAKO ... Crosstress Medical receives 510(k) clearance for PVA Pod System ... PlusLife's Allogeneic Bone Gel for sale ... Integra announces first implantation of the Titan Reverse Shoulder System ... RTI Surgical's first implantation of the map3 Cellular Allogeneic Bone Graft ... Mazor Robotics to raise up to $46M in Nasdaq offering and announces new Renaissance installation in Russia more

New Study Quantifies Societal Benefits of Knee Arthroplasty BY ANDREW VAHRADIAN, AUGUST 28, 2013

As stated by Dr. John Tongue, former President of the American Academy of Orthopaedic Surgeons (AAOS), when a knee arthroplasty (replacement) is performed on patients at the appropriate time, it adds "tremendous" value in improving one's quality of life, allowing... more

Gender: An Important Parameter for Personalized Medicine BY ANDREW VAHRADIAN, AUGUST 26, 2013

The FDA’s Center for Devices and Radiological Health (CDRH) has launched its Health of Women Program, an initiative focused on improving women’s access to, and outcomes from, treatments incorporating medical devices. The initiaitive highlights that: 1) Women are less frequently... more

Bioactive Glass Scaffolds Demonstrate Potential as Weight-bearing Implants BY ANDREW VAHRADIAN, AUGUST 1, 2013

Researchers at Missouri University of Science and Technology have developed a type of glass implant that could one day be used to repair injured bones in the arms, legs and other areas of the body that are most subject to... more

Smith & Nephew to Acquire Assets from Plato Grup BY ANDREW VAHRADIAN, JULY 11, 2013

Smith & Nephew announced an agreement to acquire certain assets related to the distribution of its orthopedic reconstruction, trauma and sports medicine products in Turkey, currently conducted through Plato Grup. The acquisition is being made through the local subsidiary of... more

Cholesterol-lowering Statins Could Lead to Musculoskeletal Injuries BY ANDREW VAHRADIAN, JUNE 25, 2013

A report published by JAMA Internal Medicine determined that while utilizing cholesterol-lowering statins can lower cardiovascular illnesses and death, it could also lead to musculoskeletal arthropathies and injuries associated with a wide variety of clinical presentations, including muscle weakness, muscle... more

Wright Medical to Divest OrthoRecon Business to MicroPort BY ANDREW VAHRADIAN, JUNE 20, 2013

Wright Medical announced it has entered a definitive agreement with MicroPort Medical, a subsidiary of MicroPort Scientific Corporation (HK: 0853), for the acquisition of Wright's OrthoRecon business at a cash purchase price of $290 million, valuing the unit at 1.1x... more

Blue Belt Technologies Announces US FDA Clearance to Market its STRIDE Unicondylar Knee System BY EDITOR, JUNE 5, 2013

Blue Belt Technologies, Inc., an innovative medical technology company commercializing robotic-assisted solutions for orthopedic surgery, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its STRIDE Unicondylar Knee implant system. The... more

Musculoskeletal News Roundup 23-May-2013 BY LAUREN UZDIENSKI, MAY 23, 2013

MDT reports earnings ... OsteoGeneX receives SBIR grant ... FDA panel votes to reclassify pedicle screws for the thoracolumbosacral class II ... Depuy Synthes to discontinue ULTAMET Metal-on-Metal Articulation and COMPLETE Ceramic-on-Metal hip systems ... KFx receives new patents ... Benvenue Medical completes follow-up for KAST study ... Globus files suit against Depuy Synthes ... Blue Belt partners with DJO ... EOS announces Asia expansion ... Stryker and OrthoSensor extend co-marketing agreement for VERASENSE more

Blue Belt Technologies Announces Co-Marketing Agreement with DJO Orthopedics BY EDITOR, MAY 20, 2013

Blue Belt Technologies, Inc., an innovative medical technology company commercializing robotic solutions for orthopedic surgery, announces an implant partnership with DJO Surgical, a DJO Global Company. Blue Belt’s NavioPFS orthopedic surgical system provides smart planning and robotic-controlled bone preparation tools... more

Zimmer to Acquire Knee Creations BY ANDREW VAHRADIAN, MAY 2, 2013

Zimmer Holdings announced plans to acquire the business assets of Knee Creations, LLC. The company was founded in 2007 and develops surgical solutions to help cure osteoarthritis by treating defects associated with subchondral bone marrow edema (BME). The acquisition progresses... more

Blue Belt Technologies announces the first NavioPFS Unicondylar Knee Replacement surgery performed in the US BY EDITOR, FEBRUARY 14, 2013

Blue Belt Technologies, Inc., the innovative medical technology company that markets its NavioPFS orthopedic surgical system with precision robotics for unicondylar knee replacement, today announced the first three Unicondylar Knee Replacement (UKR) surgeries performed in the U.S. with the NavioPFS... more

Knee Replacements Double Over Past Two Decades BY LAUREN UZDIENSKI, OCTOBER 4, 2012

New data from CMS shows that knee replacements are on the rise, doubling over the past two decades. More TKAs are now performed than coronary-artery bypass surgeries or hysterectomies, with the absolute numbers of knee replacements increasing from 93,230 cases in 1991 to 243,802 in 2010. Over the same period, a total of 3.6 million knee replacements have been performed on Medicare patients, and projections show that 3.5 million knee replacements may be performed annually by 2030. more

Musculoskeletal News Roundup 20-Sept-2012 BY LAUREN UZDIENSKI, SEPTEMBER 20, 2012

K2M receives expanded 510(k) clearance for MESA portfolio ... ATEC announces first clinical use of NEXoss ... DJO launches Movation TKA ... KFx announces new patent ... Lanx announces ASPEN MIS results more

Musculoskeletal News Roundup 13-Sept-12 BY LAUREN UZDIENSKI, SEPTEMBER 12, 2012

FDA clears Iconacy Orthopedic Implants' I-Hip system ... Precision Spine's Slimplicity Solo Anterior Cervical Plate System 510(k)-cleared ... Amedica studies find "superior osseointegration and bacterial-resistant properties" of silicon nitride ... Ascendx Spine begins commercial shipments to Europe ... Osseon launches Osseoflex SN+ ... Smith & Nephew releases LEGION HK Hinge Knee ... NuVasive signs Premier agreement more

Musculoskeletal News Roundup 9-Aug-12 BY LAUREN UZDIENSKI, AUGUST 8, 2012

ATEC, TRNX announce earnings ... DePuy receives 510(k) for adolescent idiopathic scoliosis products ... ulrich medical launches golden gate Lateral Plate System ... WMGI subpoenaed over Profemur more

Gel-One HA Injection Found Not to Infringe BY JOHN MCCORMICK, AUGUST 7, 2012

Last week, Hyaluronic acid (HA) manufacturer Seikagaku and its distribution partner Zimmer were determined by a U.S. federal jury not to infringe on Genzyme's Synvisc-One HA injection. more

Musculoskeletal News Roundup 26-Jul-12 BY LAUREN UZDIENSKI, JULY 25, 2012

CNMD, Globus, IART, NUVA, OFIX, ZMH report 2Q:12 ... Histogenics raises $49M ... FH Orthopedics receives CE mark ... Discgenics receives stem cell patent ... Exactech, CONMED to collaborate on education program more

Musculoskeletal News Roundup 7-June-12 BY LAUREN UZDIENSKI, JUNE 7, 2012

J&J/Synthes deal may close next week ... Mindray to acquire controlling interest in Chinese orthopedic manufacturer ... FDA clear's Medicrea's LigaPASS ... K2M launches MESA Small Suture implant ... SNN voluntarily withdraws the optional metal liner component of its R3 Acetabular System ... ISTO receives U.S. patent ... SYK close to settling DOJ investigation into OtisKnee ... SANUWAVE comments on preclinical data more

Musculoskeletal News Roundup 24-May-12 BY LAUREN UZDIENSKI, MAY 24, 2012

Medtronic reports earnings ... AxioMed closes Series D round ... Mazor launches C-OnSite ... BlueCross BlueShield of Tennessee announces bundled payments for hip and knee replacements ... Baxano completes enrollment on iO-Flex study ... Benvenue announces Board appointments more

Musculoskeletal News Roundup 17-May-12 BY LAUREN UZDIENSKI, MAY 17, 2012

aap, Corin, Mazor, TiGenix provide 1Q sales ... Regenerative Sciences raises $2M ... Regentis Biomaterials raises $10M ... Zyga raises $25M ... Axiomed receives CE mark for Freedom Cervical Disc ... Orthopaedic Implant Company launches pedicle screw system ... DOJ closes InFuse investigation ... Histogenics, Piramal announce cartilage repair data more

Musculoskeletal News Roundup 10-May-12 BY LAUREN UZDIENSKI, MAY 10, 2012

ATEC, ANIK, BMTI, MAKO, TRNX, TSON report 1Q ... OrthoSensor raises $15M ... Internal Fixation Systems announces distribution agreement with Intelligent Orthopaedics ... Seikagaku announces marketing agreement with Kaken for lumbar disc herniation treatment ... Bioventus officially launched more

Clinical Roundup May 2012 BY LAUREN UZDIENSKI, MAY 10, 2012

Use of fibrin sealant QUIXIL in TKAs ... The accuracy of imaging in spine surgery ... ACL revision data from Denmark ... Ankle surgery and weight loss ... More surgeons working for hospitals more

Can Oral Bacteria Cause a Joint Replacement to Fail? BY LAUREN UZDIENSKI, APRIL 25, 2012

Researchers at Case Western Reserve University may have found a potential link between gum disease and joint health, with particular implications for failing joint replacements. Working collaboratively, dental, orthopedic and arthritis specialists tested the DNA in synovial fluid in 36 patients with both native and replacement joints. Some samples showed the presence of oral bacteria in the fluid, which the scientists suggest could be contributing to aseptic loosening or excessive wear in joint replacement patients when no infection is present. more

Musculoskeletal News Roundup 12-Apr-12 BY LAUREN UZDIENSKI, APRIL 12, 2012

Biomet kicks off earnings season ... FDA approves phase I Arteriocyte study for Compartment Syndrome ... Piramal receives CE mark for BST-CarGel ... Amedica announces new biologics distribution agreements ... Advanced Biologics inks deal with GPO Premier more

Clinical Roundup April 2012 BY LAUREN UZDIENSKI, APRIL 9, 2012

Cemented vs. uncemented hip hemiarthroplasty ... Returning to running after hip resurfacing surgery ... Adipose-derived stem cells in skeletal muscle-healing in a rat model ... Cortoss IDE results in vertebroplasty ... Patterns of disc degeneration ... Are local anesthetics associated with chondrotoxicity? more

Musculoskeletal News Roundup 1-Mar-12 BY LAUREN UZDIENSKI, MARCH 1, 2012

ATEC, ANIK, EXAC announce earnings ... MedShape receives $3M loan ... Globus Medical settles with FDA over NuBone ... FDA clears K2M's SANTORINI Corpectomy Cage ... Wright Medical launches CLAW II Polyaxial Compression Plating System ... TSON opens Raleigh training center more

Clinical Roundup February 2012 BY LAUREN UZDIENSKI, FEBRUARY 27, 2012

Defining conservative treatment in VCF cases ... Obesity and large joint outcomes ... Optimizing TKR rehab ... Navigation in TKR ... A review of PRP data ... Predicting recovery of walking ability in hip fracture patients more

Study: Why Women Have More ACL Injuries BY LAUREN UZDIENSKI, FEBRUARY 16, 2012

Studies have shown that women may be up to five times more susceptible to ACL tears than men. Since that trend surfaced, researchers have been speculating as to the cause, and potential reasons included more laxity in the ligament or that women have weaker or smaller ligaments compared to men. Now a new paper suggests that geometry has more to do with the risk of ACL damage than gender. more

AAOS: 5% of Adults Age 50+ Had a Knee Replaced BY LAUREN UZDIENSKI, FEBRUARY 14, 2012

The AAOS released data last week on the prevalence of knee replacement in the aging U.S. population. The study, based on sources ranging from census data to osteoarthritis reports, found that 4.7% of adults over 50 have undergone a total knee replacement. That's 4.5 million patients in absolute terms, and this trend appears to be increasing: the number of TKR surgeries doubled over the past decade, and younger patients represent the fastest-growing segment of the TKR population. more

Musculoskeletal News Roundup 9-Feb-12 BY LAUREN UZDIENSKI, FEBRUARY 9, 2012

Product launches from AAOS ... Nobel Biocare announces 4Q ... Hospitals settle Medicare fraud claims over kyphoplasty billing ... Updates on the American Joint Replacement Registry ... Stryker announces inventory management system rollout more

Zimmer, ISTO Advance Engineered Juvenile Cartilage Studies BY LAUREN UZDIENSKI, FEBRUARY 8, 2012

Zimmer and ISTO Technologies provided an update yesterday on their research program on engineered juvenile cartilage for the repair of damaged knees. The company plans to enroll up to 225 patients at 25 sites in a new phase III study, which will compare the use of the DeNovo ET Engineered Tissue Graft to microfracture for the repair of cartilage defects in the knee. more

Musculoskeletal News Roundup 2-Feb-12 BY LAUREN UZDIENSKI, FEBRUARY 2, 2012

EXAC, KNSY, RTIX, SNN announce 4Q:11 ... CartiHeal raises $5M ... ConforMIS raises $89M ... FDA clears Eden Spine's GIZA device ... NLT announces 510(k) clearance for the PROW FUSION TLIF device ... ThermoGenesis announces "encouraging" study results more

Musculoskeletal News Roundup 19-Jan-12 BY LAUREN UZDIENSKI, JANUARY 19, 2012

ZMH acquires Synvasive Technology ... Carticept, DiFusion announce funding rounds ... KFx announces ACL study results ... MedShape launches ExoShape Soft Tissue Fastener ... VG Innovations releases VerteLoc v2.5 ... Stryker settles OP-1 charges ... Zyga Technology appoints president and CEO more

"Rapid Growth" of Knee Replacement in Younger Patients BY LAUREN UZDIENSKI, JANUARY 17, 2012

Researchers in Finland have identified a 130-fold increase in incidence of total knee arthroplasty among Finnish patients younger than 59 years of age between 1980 and 2006. These data help to quantify the trend of younger patients undergoing knee replacement procedures while illustrating the need for more data on the long-term durability of knee devices. more

Musculoskeletal News Roundup 12-Jan-12 BY LAUREN UZDIENSKI, JANUARY 12, 2012

MAKO, NUVA, OFIX, SYK, TRNX pre-announce ... FDA clears Biomet's E1 humeral bearing and Comprehensive Segmental Revision System ... Ortho Kinematics receives 510(k) clearance ... Lanx announces 100th implantation of Durango ... Mazor receives EU patent ... SNN announces VISIONAIRE study ... Arthrex to market ThermoGenesis PRP, bone marrow concentrate product ... Pioneer Surgical promotes Daniel Webber to CEO more

Musculoskeletal News Roundup 15-Dec-11 BY LAUREN UZDIENSKI, DECEMBER 15, 2011

Baxter to acquire Synovis . . . FDA approves DePuy's AOX Antioxidant Polyethylene . . . EXAC launches Gibralt spinal system . . . CMS proposes industry relationships disclosure . . . Spinal Kinetics wins patent suit . . . Amp Orthopedics initiates two new studies . . . Vertiflex completes IDE enrollment . . . K2M names SVP Sales in the Americas more

Musculoskeletal News Roundup 8-Dec-11 BY LAUREN UZDIENSKI, DECEMBER 7, 2011

Mazor reports earnings . . . HealthpointCapital acquires Blue Belt Technologies . . . DFINE receives regulatory clearance in Canada and Mexico . . . LDR approved to market ROC-C cervical cage, ROI-A ALIF cage in China . . . Ranier receives CE mark for Cadisc-C . . . DePuy launches Expedium Neuromuscular System . . . Exactech extends DPA . . . CA sobpoenas MDT over Infuse . . . IART opens China office . . . JNJ names Michel Orsinger worldwide chairman of its Global Orthopedics Group more

Musculoskeletal News Roundup 13-Oct-11 BY LAUREN UZDIENSKI, OCTOBER 13, 2011

aap Implantate pre-announces 3Q:11 ... ISTO receives CE mark for InQu ... Biomet celebrates 35th anniversary of the Oxford partial knee ... TiGenix announces Finnish distribution for ChondroCelect more

Musculoskeletal News Roundup 25-Aug-11 BY LAUREN UZDIENSKI, AUGUST 25, 2011

Corin, Medtronic announce earnings . . . FDA clears DePuy's TRUMATCH Solutions . . . Ellipse Technologies receives 510(k) clearance . . . FDA expands Zyga's indications for the SImmetry Sacroiliac Joint Fusion System . . . Mesoblast announces first phase II procedure evaluating MPCs for the treatment of low back pain . . . VG Innovations launches modified VerteLoc system . . . Sanuwave and Spinal Restoration receive U.S. patents . . . Zyga Technologies enrolls first EU patients in GLYDER study more

Chicago Surgeons Give Back BY LAUREN UZDIENSKI, AUGUST 8, 2011

Founded in 1995, Operation Walk is a not-for-profit organization founded in 1995 with the aim of bringing needed large joint surgeries to patients throughout the globe, primarily in the third world. Volunteer surgical teams have participated in trips to Cuba, China, Nepal, Philippines, Nicaragua, Peru, Guatemala, El Salvador, Panama and Ecuador. Now the Chicago Tribune is praising two surgeons striving to help Chicago-area patients lacking insurance or access to hip or knee replacements. more

Musculoskeletal News Roundup 28-Jul-11 BY LAUREN UZDIENSKI, JULY 28, 2011

CNMD, IART, NUVA, OFIX, RTIX, WMGI and ZMH report 2Q . . . FDA releases draft guidance on device modifications . . . Osseon launches in India . . . Carbylan Biosurgery announces results from viscosupplement study . . . Lanx comments on data at IMAST more

Musculoskeletal News Roundup 7-Jul-11 BY LAUREN UZDIENSKI, JULY 7, 2011

Amplitude sold to Apax France . . . ARTC sells vertebroplasty products . . . SpineVision raises $5M . . . Medtronic launches CD HORIZON Fenestrated Screw in Europe . . . RTI Biologics launches BioAdapt DBM Foam . . . DFINE study suggests lower cement leakage rate for Radiofrequency Targeted Vertebral Augmentation . . . MEDICREA to launch pilot study for GRANVIA-C cervical disc more

Musculoskeletal News Roundup 30-Jun-11 BY LAUREN UZDIENSKI, JUNE 30, 2011

Stryker completes Orthovita tender offer . . . ConforMIS to raise $68M . . . FDA clears Corin's highly cross-linked polyethylene liners and large diameter CoCr and BIOLOX Delta Ceramic heads . . . Aesculap launches Hydrolift Vertebral Body Replacement System . . . Cayenne Medical debuts the CrossFix II Meniscal Repair System . . . Mesoblast receives FDA clearance to begin phase II DDD study more

Musculoskeletal News Roundup 16-Jun-11 BY LAUREN UZDIENSKI, JUNE 16, 2011

Altor to acquire Orchid Orthopedic Solutions . . .Spinal Modulation closes $30M in funding . . . FDA approves DePuy's ceramic-on-metal hip . . . TSON announces 10,000th U.S. AxiaLIF implantation . . . Cayenne Medical partners with allograft supplier Parametrics more

Musculoskeletal News Roundup 2-Jun-11 BY LAUREN UZDIENSKI, JUNE 2, 2011

BioPoly receives CE mark for knee resurfacing system . . . ConforMIS receives CE mark for the iTotal CR . . . FDA clears Nimbic Systems' Air Barrier System . . Exactech launches the Proliant Polyaxial Pedicle Screw system . . . Zimmer showcases new products at EFORT more

Musculoskeletal News Roundup 28-Apr-11 BY LAUREN UZDIENSKI, APRIL 28, 2011

CNMD, IART, SYST, ZMH and more report earnings . . . FDA clears Biomet's Active Articulation E1 Dual Mobility Hip System . . . ORTHOCON receives EU, Canadian clearance to market HEMASORB . . . SI-BONE receives modification to its labeling . . . DJO Global introduces e-plus total knee replacement insert . . . Wright Medical launches FUSIONFLEX Demineralized Moldable Scaffold . . . Kuros regains certain technology rights from Baxter . . . Genzyme files two new HA infringement suits more

Musculoskeletal News Roundup 24-Mar-11 BY LAUREN UZDIENSKI, MARCH 24, 2011

China Kanghui reports earnings, announces acquisition . . . FlexFix to acquire assets from Novalign . . . Newly-formed Rachiotek to acquire Applied Spine Technologies . . . Core Essence raises $11.5M . . . LDR submits PMA for two-level Mobi-C . . . FDA clears TSON's AxiaLIF 1L+ . . . FDA approves Seikagaku's single-injection HA . . . Pioneer Surgical launches the the Streamline TL Spinal Fixation System . . . Spinal Kinetics announces 10,000th implantation of M6 Disc . . . Medtronic of Canada releases data from study on kyphoplasty in cancer patients . . . Zimmer signs Department of Defense contract more

Musculoskeletal News Roundup 17-Mar-11 BY LAUREN UZDIENSKI, MARCH 17, 2011

Biomedical Structures acquires Concordia Medical . . . Neue Magnetodyn IP to go up for auction . . . Wright Medical closes tender offer for convertible senior notes . . . K2M receives CE mark for RAVINE Lateral Access and ALEUTIAN Lateral Interbody Systems . . . Smith & Nephew files suit against former employees . . . OrthAlign comments on new clinical data . . . Misonix, Aesculap sign new distribution agreement . . . Shukla Medical licenses Kytogenics' biopolymer technology . . . Inion resumes operations . . . DePuy Spine appoints worldwide president more

Musculoskeletal News Roundup 10-Mar-11 BY LAUREN UZDIENSKI, MARCH 10, 2011

ANIK, BMTI, VITA report 4Q . . . Global Biotech to take minority position in BoneGrafix . . . ConforMIS to raise $1.8M . . . Medtronic launches ATLANTIS VISION ELITE cervical plate system . . . Wright Medical launches PRO-TOE VO . . . OFIX receives subpoena . . . Vertos announces mild clinical data . . . GenOsteo and SpineSmith to collaborate on stem cell scaffold . . . RegeneCure licenses synthetic membrane for use with stem cells . . . Bacterin now trading on NYSE Amex more

Musculoskeletal News Roundup 17-Feb-11 BY LAUREN UZDIENSKI, FEBRUARY 17, 2011

ARTC, DJO, GENZ, OFIX and Synthes report earnings . . . Sonoma raises $22 million . . . Anika provides FDA update . . . AAOS product launches . . . Medtronic announces kyphoplasty data more

Musculoskeletal News Roundup 3-Feb-11 BY LAUREN UZDIENSKI, FEBRUARY 3, 2011

CNMD, KNSY, RTIX report 4Q . . . Spine Wave raises $17.5M . . . Vertiflex raises $14M . . . Tornier goes public . . . BioMimetic Therapeutics gets FDA panel hearing date . . . ConforMIS knee system cleared . . . Healthcare reform found unconstitutional in Florida . . . Wright Medical expands supply agreement for GraftJacket . . . Biomet makes a donation to OREF more

Musculoskeletal News Roundup 13-Jan-11 BY LAUREN UZDIENSKI, JANUARY 13, 2011

MAKO, NUVA, SYK pre-announce . . . Globus acquires Facet Solutions' assets . . . Doctors Research Group raises $7.7M . . . Wright Medical launches DARCO system in Japan . . . Zimmer introduces NexGen LPS-Flex Mobile Bearing Knee with Prolong Highly Crosslinked Polyethylene . . . FDA approves Wright Medical's IDE for the INBONE Total Ankle Replacement with Calcaneal Stem . . . China Kanghui Holdings and Consensus Orthopedics announce manufacturing and marketing agreement more

Zimmer Closes China Acquisition BY JOHN MCCORMICK, DECEMBER 21, 2010

This morning Zimmer announced that it has finalized its acquisition of China-based Beijing Montagne, a mainland company that develops large joint implants and instruments. more

Musculoskeletal News Roundup 2-Dec-10 BY LAUREN UZDIENSKI, DECEMBER 2, 2010

Synovis reports F4Q:10 . . . MiMedx receives $0.2 million in grant funding . . . Ortho Kinematics raises $1.0 million . . . Medtronic's CD HORIZON pedicle screw system cleared for adolescent idiopathic scoliosis . . . Smith & Nephew receives expanded CE mark clearance for DUROLANE . . . DePuy Spine launches the MOUNTAINEER Laminoplasty System . . . Spine publishes SCOLISCORE AIS data . . . Australian large joint registry data shows 98% success rate for ceramicized metal technology more

Musculoskeletal News Roundup 24-Nov-10 BY LAUREN UZDIENSKI, NOVEMBER 24, 2010

MDT reports F2Q:11 . . . Bacterin, Sonoma Orthopedics announce financing rounds . . . curasan AG receives Health Canada approval for Cerasorb M ORTHO . . . Medtronic launches SOVEREIGN Spinal System in Europe . . . Blue Cross Blue Shield of North Carolina releases new lumbar spinal fusion guidelines . . . Stryker supports South Carolina medtech development consortium more

Musculoskeletal News Roundup 11-Nov-10 BY LAUREN UZDIENSKI, NOVEMBER 11, 2010

ATEC, ANIK, KH and TSON announce 3Q . . . SYST acquires surgical power tools . . . MAKO closes public offering . . . ConforMIS launches next-generation iDuo G2 . . . SYK's Triathlon knee has lowest three-year revision rate compared to competitive systems, according to U.K. data . . . SYK receives subpoenas related to OtisKnee and PainPump . . . Arthrex to distribute KNSY's Cartilage Repair Device in Europe more

AAOS Launches Joint Registry Pilot Program BY LAUREN UZDIENSKI, OCTOBER 13, 2010

A national large joint registry championed by AAOS will be launched this month as a pilot program at 15 hospitals. The registry will track results based on details about patients, doctors, hospitals and implants with the aim of improving outcomes, and many large-joint manufacturers have voiced their support for the program. more


The New York Times reports this morning on a hereditary predisposition to ACL tears. A study published in the British Journal of Sports Medicine noted several risk factors for ACL tears that were common between twins, furthering data from a year earlier that identified specific genetic markers that correlated to knee injuries. more

Musculoskeletal News Roundup 23-Sept-10 BY LAUREN UZDIENSKI, SEPTEMBER 23, 2010

M&A Amedica acquired US Spine for an undisclosed amount. The target company manufactures a range of fusion products as well as the Facet Fixation System, which features the Facet Gun to lock the facet joint. Amedica says that with the... more

Patient Outcomes Similar for Gender-Specific and Conventional Knees BY LAUREN UZDIENSKI, AUGUST 24, 2010

Patients who received both a gender-specific and a conventional knee replacement had similar outcomes and reported no preference between the two, according to new data published in JBJS. more

Musculoskeletal News Roundup 19-Aug-10 BY LAUREN UZDIENSKI, AUGUST 19, 2010

Medtronic to acquire Osteotech . . . Stryker may buy Boston Scientific's neuromodulation unit . . . SI-Bone raises $11M . . . Aesculap received 510(k) clearance for the A-Fix Spinal System . . . Biomet responds to FDA warning letter . . . Benvenue Medical announces first U.S. use of the Blazer system for treating VCFs . . . Cytori receives patent for stem cell use in musculoskeletal applications . . . NuOrtho Surgical announces pre-clinical results . . . RTI Biologics reports "no change" to Medtronic supply agreement more

With an Eye on Consulting Relationships, Sen. Grassley Probes Reporting Practices at Zimmer BY LAUREN UZDIENSKI, AUGUST 2, 2010

Zimmer received a letter from Sen. Chuck Grassley requesting data on the company's processes for tracking failure rates of its large joint systems, specifically when safety issues are raised by company consultants. more

Ortho Gets a TED Talk BY JOHN MCCORMICK, JULY 26, 2010

Watching TED talks on iTunes - or an iPad for that matter - is the futurist's equivalent of a basketball fan's immersion into March Madness. TED, which stands for Technology, Entertainment, Design is a non-profit organization devoted to spreading forward-thinking... more

Zimmer Expanding China Presence BY JOHN MCCORMICK, JULY 22, 2010

Zimmer's data rich earnings announcement this mornining contained an interesting nugget about their China plans. Zimmer announced that they have completed a definitive agreement to acquire Beijing Montagne Medical Device Co., Ltd. a 360-employee company that develops large joint implants... more

Prototype Device Detects Osteoarthritis by Sound BY LAUREN UZDIENSKI, JULY 22, 2010

The BBC reported this week on a non-invasive device that can detect early-stage osteoarthritis using sound. Researchers at the universities of Lancaster and Central Lancashire have developed acoustic techniques that can detect changes in the normal patterns of sounds in the knee, which the developers say can predict the onset of osteoarthritis. more

Musculoskeletal News Roundup 24-Jun-10 BY LAUREN UZDIENSKI, JUNE 24, 2010

Baxano closes $30M series C . . . SpineForm, Lanx, OrthoHelix receive $1M Ohio Third Frontier Commission awards . . . Aesculap launches S4 MIS Cannulated Pedicle Screw Spine Fusion System . . . Medtronic launches KYPHON ActivOs 10 Bone Cement with Hydroxyapatite . . . SNN granted injunction against Arthrex . . . Senate passes Medicare pay patch . . . Kensey Nash, Arthrex sign agreement over KNSY's ECM . . . Therapure, ProChon Biotech ink manufacturing deal . . . NuVasive leases NJ office space . . . BioTime creates new stem cell subsidiary more

Tornier Files for IPO BY JOHN MCCORMICK, JUNE 8, 2010

Despite recent market turmoil, fast-growing extremities implant leader Tornier made a confident statement about its business outlook by filing for a $205 million initial public offering (IPO) yesterday. After a 16-month nuclear winter, healthcare IPOs came back with a vengeance... more

Musculoskeletal News Roundup 27-May-10 BY LAUREN UZDIENSKI, MAY 27, 2010

Medtronic announces FQ4 . . . Exactech acquires Brighton Partners, supplier of Optetrak knee material . . . VentureMD closes funding round . . . KFx cleared to market AppianFx knee products . . . X-spine receives FDA clearance for Fixcet Spinal Facet Screw System . . . Applied Spine awarded patents . . . DFine, Vertos release clinical data . . . curasan collaborates with Matricel on bone graft substitute . . . SpineGuard appoints Alan Olsen Chairman of the Board more

Musculoskeletal News Roundup 15-Apr-10 BY LAUREN UZDIENSKI, APRIL 15, 2010

Biomet kicks off earnings seasons . . . ATEC preannounces . . . Articulinx, biospace med, Osseon close funding rounds . . . ConforMIS G2 Uni receives CE mark clearance . . . EXAC's Novation hip approved for sale in Japan . . . Stryker Interventional Spine launches iVAS for VCFs . . . Cayenne Medical announces clinical results for the AperFix System more

Musculoskeletal News Roundup 1-Apr-10 BY LAUREN UZDIENSKI, APRIL 1, 2010

xray_small.jpgATEC closes Scient'x acquisition . . . Anulex and Carticept Medical close funding rounds . . . OrthAlign receives 510(k) clearance for its latest KneeAlign design . . . Eden Spine receive a European patent . . . Medicare cuts loom as Congress departs for Easter recess . . . ArthroCare reports data on their Plasma Disc Decompression products more

Musculoskeletal News Roundup: AAOS Edition BY LAUREN UZDIENSKI, MARCH 11, 2010

OR_small.jpg The latest news from AAOS! VITA and MAKO report 4Q09 . . . ETEX receives 510(k) . . . DePuy, Integra, Medtronic, Smith & Nephew and more announce product launches . . . SEC Drops Wright Medical Investigation . . . BioMimetic Therapeutics shares study results . . . Long-term use of bisphosphonates may increase fracture risk . . . NeoStem wins research grant more

Musculoskeletal News Roundup 25-Feb-10 BY LAUREN UZDIENSKI, FEBRUARY 25, 2010

xray_small.jpgAlphatec Spine reported 4Q:09 revenues of $36.6 million, an increase of 29% from the $28.4 million reported in 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. Asian revenues were $6.6 million, an increase of 38% from the $4.8 million reported for 4Q:08. European revenues in 4Q:09 were $1.7 million. more

TKA Patients Gain More Weight Post-Op Compared to Healthy Controls BY LAUREN UZDIENSKI, FEBRUARY 23, 2010

Despite the increased mobility associated with total knee replacement, a new study found that TKA patients actually gain more weight post-operatively than non-surgical controls. The study, published in Osteoarthritis and Cartilage, enrolled 106 TKA patients and 31 non-surgical controls. The... more

Blue Cross and Blue Shield Names Spine, Large Joint Centers to its Blue Distinction Program BY LAUREN UZDIENSKI, FEBRUARY 16, 2010

Blue Cross and Blue Shield announced that they would broaden their "Blue Distinction" designation granted to high-performing hospitals to include spine and hip and knee centers. Blue Distinction hospitals have met objective, "evidence-based thresholds for clinical quality and safety" and... more

Orthopedics in China and the U.S.: An Interview with HealthpointCapital's Chinese Research Scholar BY JOHN MCCORMICK, FEBRUARY 8, 2010

Starting in October 2009, HealthpointCapital initiated a one-year Research Scholarship at the Hospital for Special Surgery (HSS) for a select oprthopedic surgeon from China. This month, we checked in with our Research Scholar, Dr. Xiaodong Ju, to see how he... more

Musculoskeletal News Roundup 14-Jan-10 BY LAUREN UZDIENSKI, JANUARY 14, 2010

Earnings aap Implantate reported preliminary sales of EUR 7.4 million ($10.6 million) in 4Q:09, down 4% from the year-ago period. Full year sales were up 3% to EUR 33.0 million ($47.3 million). Company highlights for the year include "optimizing its... more

Anika Acquires Fidia Advanced Biopolymers for ~$34M BY LAUREN UZDIENSKI, JANUARY 4, 2010

On December 31, Anika Therapeutics announced the acquisition of Fidia Advanced Biopolymers for $17.1 million in cash and 1.9 million shares of stock, which values the deal at roughly $34.0 million. Fidia is a tissue engineering company based in Abano... more

Ortho Products Top List of 2009 Health Innovations BY LAUREN UZDIENSKI, DECEMBER 21, 2009

CNN published a list of the top 10 health innovations of 2009, and two orthopedic products made the list: a bone graft substitute made from wood and the economical Jaipur Knee. Researchers in Italy have discovered a way to convert... more

Musculoskeletal News Roundup 17-Dec-09 BY LAUREN UZDIENSKI, DECEMBER 17, 2009

M&A Alphatec Holdings, Inc. announced that it has entered into a definitive agreement to acquire Scient'x Groupe SAS, a spinal implant company headquartered in France. The transaction is structured as an all-stock transaction such that 100% of outstanding Scient'x stock... more

JBJS: The Latest in Adult Reconstructive Knee Surgery BY LAUREN UZDIENSKI, DECEMBER 11, 2009

This month JBJS published an overview from Drs. Carl Deirmengian and Jess Lonner on the latest clinical developments and trends in knee reconstruction. The paper was based on a review of new knee literature in 2008. Below is a summary... more

Musculoskeletal News Roundup 3-Dec-09 BY LAUREN UZDIENSKI, DECEMBER 3, 2009

M&A Stryker entered into a definitive agreement to acquire Ascent Healthcare Solutions, a medical device reprocessing company, for $525.0 million in cash. Ascent describes its operations as including the "cleaning, testing/verifying, packaging and sterilizing" or devices, as well as "remanufacturing,"... more

Musculoskeletal News Roundup 19-Nov-09 BY LAUREN UZDIENSKI, NOVEMBER 19, 2009

Earnings ArthroCare restated its earnings from 2004 through 2Q:09. The company reported total revenue for 2008 of $314.2 million, up 12% over 2007. Relative to prior-year periods, 1Q:09 revenues increased 2% to $78.8 million; 2Q:09 revenues decreased 6% to $80.8... more

Musculoskeletal News Roundup 22-Oct-09 BY LAUREN UZDIENSKI, OCTOBER 22, 2009

Earnings CONMED reported 3Q:09 sales of $175.5 million, down 2% from the year-ago period and beating estimates by $1.4 million. Arthroscopy sales were up 2% and powered instrument sales were flat. Non-GAAP diluted EPS of $0.28 beat estimates by $0.12.... more

Biomet Acquires Cartilix BY LAUREN UZDIENSKI, OCTOBER 20, 2009

Biomet has acquired the assets of Cartilix for an undisclosed sum. The target company is developing ChonDux, a new technology that uses a biological adhesive and hydrogel to fill lesions in the articular cartilage. Previous investors in the company include... more

Musculoskeletal News Roundup 8-Oct-09 BY LAUREN UZDIENSKI, OCTOBER 8, 2009

Earnings TranS1 pre-announced 3Q:09 revenues, saying sales for the quarter would be in the range of $6.8 to $6.9 million. This represents a 15% increase over year-ago sales, though it is below 3Q:09 guidance of $7.4 to $7.9 million. Analysts... more

ChrondroCelect Receives First-of-Its-Kind EU Market Clearance BY LAUREN UZDIENSKI, OCTOBER 8, 2009

TiGenix announced that ChondroCelect, its ACI treatment for cartilage regeneration, has been cleared by the European Commission for sale on the EU market. This is the first product to be approved in the EU as an advanced therapy medicinal product,... more

Musculoskeletal News Roundup 17-Sept-09 BY LAUREN UZDIENSKI, SEPTEMBER 17, 2009

M&A Integra LifeSciences acquired the assets of Innovative Spinal Technologies, Inc. (IST) for $9.25 million in cash. Last year the company recorded $2.2 million in revenues, though they ceased operations in January and went into liquidation in May. This transaction... more

JBJS: Orthopedics in 2020 BY LAUREN UZDIENSKI, SEPTEMBER 10, 2009

An article in JBJS outlined the evolving need for musculoskeletal care in the coming decade, addressing changes in demographics, disease incidence, treatment modalities and delivery of orthopedic services. These factors illustrate some of the growth drivers in orthopedics and help... more

Musculoskeletal News Roundup 3-Sept-09 BY LAUREN UZDIENSKI, SEPTEMBER 3, 2009

Regulatory Active Implants Corporation received a CE Class III Certificate for its TriboFit Hip System. The system is made from a low-wear polycarbonate-urethane material that the company says shares some of the characteristics of human cartilage. MEDICREA received 510(k) clearance... more

Musculoskeletal News Roundup 20-Aug-09 BY LAUREN UZDIENSKI, AUGUST 20, 2009

Earnings aap Implantate reported 1H:09 sales of EUR 14.7 million ($20.7 million), representing a 10% decreased from 1H:08. Adjusting for one-time income, sales were down 3%, and in the second half of 2009, the company "anticipates a recovery in demand... more

FDA Panel Votes Against Durolane BY LAUREN UZDIENSKI, AUGUST 19, 2009

An FDA panel determined in a 6-1 vote that Q-Med's single-injection Durolane, a hyaluronic acid, should not receive market approval. The panel raised efficacy concerns based on study data showing limited benefit for the product compared to placebo. The panel... more

Protein May Predict Severe Osteoarthritis BY LAUREN UZDIENSKI, AUGUST 18, 2009

Researchers have identified a protein marker that predicts the onset of severe OA, according to a study published in the journal Arthritis & Rheumatism. Seeking an OA predictor apart from age and weight, scientists focused on vascular cell adhesion molecule... more

Musculoskeletal News Roundup 13-Aug-09 BY LAUREN UZDIENSKI, AUGUST 13, 2009

Earnings BioMimetic Therapeutics reported 2Q:09 royalty and sublicense revenue of $0.4 million, missing estimates by $0.1 million. The company reported a net loss of $6.3 million, or $0.32 per share, beating estimates by $0.17. Among the highlights for the quarter... more

ConforMIS Raises $50 Million BY JOHN MCCORMICK, JULY 14, 2009

Custom knee resurfacing implant developer ConforMIS announced that it has raised $50 million from a group of private equity firms and non-US government investment funds. This 2004 start-up has steadily developed a technology that turns patient imaging data into custom... more

Musculoskeletal News Roundup 9-Jul-09 BY LAUREN UZDIENSKI, JULY 9, 2009

Earnings Exactech announced that 2Q:09 revenues would be approximately $43.0 million, below earlier guidance and analyst expectations of approximately $45.0 million. The range for full-year 2009 revenue guidance has also been lowered to $167-$173 million. The company attributed 2Q's sales... more

Total Knee Arthroplasty is Cost-Effective BY LAUREN UZDIENSKI, JUNE 24, 2009

A new study published in the Archives of Internal Medicine affirmed the cost-effectiveness of total knee replacements in elderly patients, finding that the procedure cost $18,300 per quality-adjusted life year (or QALY) gained. The threshold for cost-effectiveness is usually estimated... more

House Proposes Artificial Joint Registry BY LAUREN UZDIENSKI, JUNE 22, 2009

Representatives Bill Pascrell Jr. (D-NJ) and Lloyd Doggett (D-TX) introduced a bill in the House last week that would establish a U.S. joint registry. If the registry is established, the U.S. would follow Australia, England and Sweden in creating similar... more

Musculoskeletal News Roundup 28-May-09 BY LAUREN UZDIENSKI, MAY 28, 2009

Regulatory Blackstone Medical received an FDA warning letter relating to the ICON Modular Spinal Fixation System, which the company voluntarily recalled in December of 2005. The FDA said Blackstone failed to adhere to its own risk management procedures and failed... more

Early Earnings Reports Show Growth Despite Economy BY LAUREN UZDIENSKI, APRIL 16, 2009

DePuy and Biomet have kicked off 1Q earnings season on a positive note, offering a view of industry growth that may be outpacing expectations. These two companies, which together comprise more than a third of the ortho market, reported 7%... more

Musculoskeletal News Roundup 9-Apr-09 BY LAUREN UZDIENSKI, APRIL 9, 2009

Earnings Biomet reported FQ3:09 revenues of $615 million, a 7% (constant currency) increase over FQ3:08. Among segments, recon reported growth of 7%, with hip up 10%, knee up 9%, fixation up 4% and dental down 10%, which the company attributed... more

WSJ Reports on ReGen's Campaign Donations BY LAUREN UZDIENSKI, APRIL 7, 2009

The WSJ published additional details of its investigation into ReGen Biologics' FDA clearance for its Menaflex meniscal implant. New information out this morning includes details of campaign donations from ReGen executives to the New Jersey politicians who stood behind ReGen... more

Four of Big Five Settle with DOJ; Compliance Monitors Leave BY DAVID KRESSEL, MARCH 31, 2009

Eighteen months after the Department of Justice entered into Deferred Prosecution Agreements (DPA) with Smith & Nephew, Johnson & Johnson (Depuy), Zimmer and Biomet, and a Non-Prosecution Agreement with Stryker, the DOJ has announced it has dismissed the criminal charges... more

Musculoskeletal News Roundup 19-Mar-09 BY LAUREN UZDIENSKI, MARCH 19, 2009

Earnings TiGenix announced 2008 financial results this week, reporting a widening net loss as the company prepares to launch ChondroCelect in Europe. The company's net loss was EUR 15.2 million ($21.4 million), an increase of 27% over 2007. As the... more

Musculoskeletal News Roundup 26-Feb-09 BY LAUREN UZDIENSKI, FEBRUARY 26, 2009

Earnings Artimplant reported 4Q:08 revenues of SEK 4.6 million ($0.6 million), down from SEK 5.0 million ($0.8 million) in 4Q:07. During the quarter, the company reported sales of 900 Artelon Spacers (down from 1,100 in 4Q:07) and 300 units of... more

Musculoskeletal News Roundup 19-Feb-09 BY LAUREN UZDIENSKI, FEBRUARY 20, 2009

Earnings Exactech reported 4Q:08 revenues of $40.3 million, representing a 22% increase over 4Q:07 and beating estimates by $0.4 million. Net income was $3.1 million, or $0.24 per share, representing a 15% increase over 4Q:07 and beating estimates by $0.04.... more

Musculoskeletal News Roundup 5-Feb-09 BY LAUREN UZDIENSKI, FEBRUARY 5, 2009

Earnings CONMED Corp. reported 4Q:08 revenues of $179.2 million, down 5% versus 4Q:07 and beating estimates by $2.26 million. Non-GAAP diluted earnings per share were $0.34, down 23% from 4Q:07 and beating estimates by $0.05. The company reported 4Q:08 arthroscopy... more

New MRI Technique Detects OA Before Symptom Onset BY LAUREN UZDIENSKI, JANUARY 29, 2009

Researchers at Stanford University are developing sodium MRI, an imaging technique that can identify signs of cartilage deterioration up to decades before a patient exhibits symptoms of osteoarthritis. A standard MRI emits electromagnetic energy that excites protons in water molecules.... more

Musculoskeletal News Roundup 29-Jan-09 BY LAUREN UZDIENSKI, JANUARY 29, 2009

Earnings Kensey Nash reported FQ2:09 revenues of $20.8 million, up 6% over the year-ago period and beating estimates by $0.4 million. Net income for the quarter was $5.2 million, or $0.44 per diluted share, beating estimates by $0.04 and representing... more

WHO Tool Helps Physicians Predict Fracture Risk BY LAUREN UZDIENSKI, DECEMBER 23, 2008

In an effort to individualize treatment for patients presenting with fractured bones as well as make treatment more cost-effective, the WHO has launched a web tool to help physicians assess the likelihood of future fractures. Knowing future fracture risk can... more

Regen Biologics Gets FDA Clearance BY JOHN MCCORMICK, DECEMBER 22, 2008

This morning Regen Biologics announced that it received its long awaited FDA 510(k) clearance to market its collagen meniscus implant for the knee. This marks the end of a long and tortured back and forth between the company and the... more

Musculoskeletal News Roundup 18-Dec-08 BY LAUREN UZDIENSKI, DECEMBER 18, 2008

Funding In addition to its regularly scheduled payments, Orthofix International will make a $10 million debt prepayment on December 29th in advance of the scheduled maturity. According to Executive Vice President and CFO Bob Vaters, "This is a good time... more

For Patients in Pain, Scans May Not Offer a Diagnosis BY LAUREN UZDIENSKI, DECEMBER 9, 2008

Imaging technology may be an ubiquitous part of modern medical practice, but a New York Times article suggests that the frequency and sensitivity of MRI and CT scans may reveal musculoskeletal abnormalities without showing what causes a patient's pain. These... more

Musculoskeletal News Roundup 20-Nov-08 BY LAUREN UZDIENSKI, NOVEMBER 20, 2008

Earnings Medtronic reported FQ2:09 revenues of $3.57 billion, up 14% (8% constant currency) over the year-ago period and missing estimates by $0.12 billion. Non-GAAP net earnings and diluted earnings per share were $758.0 million, or $0.67 per diluted share, missing... more

Musculoskeletal News Roundup 25-Sept-08 BY LAUREN UZDIENSKI, SEPTEMBER 25, 2008

Funding Anulex Technologies, Inc. secured a $7.0 million growth capital term loan from Silicon Valley Bank. The company plans to use the proceeds to further their R&D efforts, complete their clinical study and expand their sales force. Anulex markets the... more

Musculoskeletal News Roundup 18-Sept-08 BY LAUREN UZDIENSKI, SEPTEMBER 18, 2008

M&A BoneSupport acquired Ultrazonix, the developer of an ultrasound-based treatment for alleviating pain associated with herniated discs. The product is FDA-cleared and CE-marked. Financial terms were not disclosed. Funding Formae received an investment of $0.5 million from BioAdvance, the Biotechnology... more

Arthroscopic Knee Surgery for OA... Is It Worth It? BY JOHN MCCORMICK, SEPTEMBER 16, 2008

Last week, the New England Journal of Medicine published a study that more or less said "no". In cautionary scientific parlance, the study concluded that "arthroscopic surgery for osteoarthritis of the knee provides no additional benefit to optimized physical and... more

Musculoskeletal News Roundup 11-Sept-08 BY LAUREN UZDIENSKI, SEPTEMBER 11, 2008

M&A Wright Medical Group, Inc. acquired the RAYHACK System for wrist reconstruction, which consists of "procedure-specific bone-cutting guides and fixation plates that allow precise shortening and repositioning of the radius and ulna." The system will be available in the U.S.... more

Medical Tourism at Home: U.S. Hospitals Competing with Foreign Pricing BY LAUREN UZDIENSKI, SEPTEMBER 10, 2008

The Wall Street Journal this morning revealed a new variation on medical tourism: patients are traveling for medical procedures, though not overseas. Medical tourism arose from skyrocketing U.S. healthcare costs; a hip replacement can cost $43,000 domestically and a mere... more

U.K. Study Finds 1 in 75 Patients Undergo Large Joint Revision BY LAUREN UZDIENSKI, SEPTEMBER 8, 2008

Data from about 160,000 U.K. patients who received hip or knee replacements between 2003 and 2006 show an overall revision rate of one in 75, or 1.4%. Overall, this rate is low, but it was affected by the type of... more

Histogenics Raises $9mm BY JOHN MCCORMICK, SEPTEMBER 2, 2008

A cartilage company raising venture money is a not-so-common development in the world of sports medicine. In this instance, Waltham, MA based Histogenics just announced it has raised $9 million from venture investors. Of interest, Stryker was included in the... more

NY Times Calls for National Joint Registry BY LAUREN UZDIENSKI, JULY 29, 2008

Following Zimmer's announcement that the company would suspend sales of the Durom acetabular cup, the New York Times suggested this morning that the concerns about Durom could've been identified sooner if the U.S. had a national joint registry in place.... more

Study Finds Hip and Knee Arthroplasty Worthwhile for the Elderly BY HAL BRIGHAM, JULY 21, 2008

A study published in the July 14, 2008 issue of Archives of Internal Medicine contends that hip and knee arthroplasty surgeries may be more beneficial to elderly patients than once believed. The study reports that surgery is not only more... more

Musculoskeletal News Roundup 17-July-08 BY LAUREN UZDIENSKI, JULY 17, 2008

Earnings Biomet reported FQ4:08 revenues of $635.6 million, an increase of 16% (10% constant currency) over the year-ago period. Sales increased 10% in the U.S and 24% (11% constant currency) OUS. Recon sales increased 17% worldwide (12% constant currency) to... more

ACL Repair for Young, Active Patients: Heightened Risks Create Opportunity for Regenerative Technologies BY LAUREN UZDIENSKI, JULY 16, 2008

Researchers at the Mississippi Sports Medicine and Orthopaedic Center have found a failure rate nearing 24% for ACL reconstruction in young, athletic patients, according to a new study. Of 61 patients aged 15-39 who underwent ACL reconstruction, 14 were deemed... more

JBJS: ReGen's Collagen Meniscus Implant Improves Clinical Outcomes for Some Patients BY LAUREN UZDIENSKI, JULY 8, 2008

A new JBJS study comparing ReGen Biologics' collagen meniscus implant, Menaflex, with partial meniscectomy was published this week, and the publication comes as a rare bit of good news for the struggling ReGen. At 311 patients, the multi-center study was... more

Knees Take the Spotlight at the New York Times and WSJ BY LAUREN UZDIENSKI, JUNE 30, 2008

Knees have been in the media spotlight lately, thanks to two recent articles appearing in the New York Times and Wall Street Journal. Both authors speak positively of their experiences with knee replacements, and the Journal paints a rosy picture... more

New "Smarthroscope" Will Assess Extent of Tissue Damage BY LAUREN UZDIENSKI, JUNE 3, 2008

Queensland University Of Technology researchers are developing a device they call a "smarthroscope," designed to be a more sensitive alternative to an arthroscope. Professor Kunle Oloyede, who received a grant from the National Health and Medical Research Council to develop... more

Female Athletes More Susceptible to ACL Tears BY LAUREN UZDIENSKI, JUNE 2, 2008

In February, the New York Times reported on a rise in pediatric ACL cases, attributed to aggressive athletic activity, the increasingly common practice of MRI scans for injured knees and physicians' heightened familiarity with pediatric ACL tears. Now an article... more

Musculoskeletal News Roundup 29-May-08 BY ARMELLE WIART, MAY 29, 2008

M&A Kinetic Concepts, Inc. announced that it completed its acquisition of LifeCell Corporation. At the time of the expiration of the tender offer, 31.1 million shares of LifeCell common stock had been tendered representing approximately 90.75% of the outstanding shares... more

Musculoskeletal News Roundup 1-May-08 BY LAUREN UZDIENSKI, MAY 1, 2008

Earnings Anika Therapeutics reported 1Q:08 total revenues of $8.55 million, an increase of 46% over the year-ago period, which the company attributed to strong domestic and international sales of ORTHOVISC. Revenues beat analysts' expectations by $0.2 million. Net income for... more

Promising ChondroCelect Data Shows Structural Superiority at Three Years BY LAUREN UZDIENSKI, APRIL 28, 2008

Just over a year ago, TiGenix published 12 and 18-month results from their ChondroCelect clinical trial that showed advantages to the ACI treatment when compared to microfracture. Now the company has released further data showing that three years following treatment,... more

Musculoskeletal News Roundup 17-Apr-08 BY LAUREN UZDIENSKI, APRIL 17, 2008

Earnings Biomet reported FQ3:08 net sales of $603.1 million, a 14% increase over the year-ago period. Excluding the impact of foreign currency, net sales increased 10%. U.S. revenue was $351.6 million. Adjusted net income for the third quarter was $25.2... more

Musculoskeletal News Roundup 3-Apr-08 BY LAUREN UZDIENSKI, APRIL 3, 2008

Earnings aap Implantate reported 2007 revenue of EUR 28.0 million ($41.24 million), an increase of 52% over 2006. Net profit for the year was EUR 1.5 million ($2.21 million), down from EUR 1.6 million ($2.36 million) in 2006, which the... more

When Evaluating Knee OA, Patient Gender Affects Whether a Physician Recommends Surgery BY LAUREN UZDIENSKI, MARCH 20, 2008

According to a new study reported on by the New York Times, patient gender appears to influence whether physicians recommend they have a knee replaced. In a Canadian study, a male patient was told twice as often to have the... more

Musculoskeletal News Roundup 13-Mar-2008 BY LAUREN UZDIENSKI, MARCH 13, 2008

Earnings BioMimetic Therapeutics reported 4Q:07 revenues of $4.5 million, up from $1.9 million in 4Q:06 but missing analysts' estimates by $1.1 million. Revenues included $3.6 million of product sales of GEM 21S to Luitpold, $0.7 million of royalty income and... more

AAOS: New Research Shows Hip, Knee Replacements Skyrocketing, Plus the Efficacy of Gender Implants and Hip Resurfacing BY LAUREN UZDIENSKI, MARCH 12, 2008

Clinical research presented at AAOS's annual meeting included a number of large-joint studies, one of which showed that hip and knee replacement procedures will climb to 572,000 and 3.4 million, respectively, in 2030. That's 101% more hip replacements and 525%... more

Musculoskeletal News Roundup 6-Mar-08 BY LAUREN UZDIENSKI, MARCH 6, 2008

Earnings Anika Therapeutics reported 4Q:07 product revenue of $7.9 million, in line with estimates and up from $5.08 million for the same period last year. The revenue growth was attributed to domestic and international sales of the ORTHOVISC product line,... more

MAKO Surgical Goes Public BY JOHN MCCORMICK, FEBRUARY 17, 2008

On Thursday of last week, MAKO Surgical Corp went public. The Company, which makes robotic arms for minimally inveasive knee surgery, raised an impressive $51 million in capital selling at $10 a share. Although it lost some ground on the... more

Musculoskeletal News Roundup 7-Feb-08 BY LAUREN UZDIENSKI, FEBRUARY 7, 2008

Earnings Smith & Nephew announced 4Q:07 revenues of $967.0 million, beating estimates of $933.0 million and reflecting a 25% (reported) increase over 4Q:06. Adjusted earnings per share was $0.16, in line in estimates and up 10% over the year-ago period.... more

Musculoskeletal News Roundup 25-January-08 BY LAUREN UZDIENSKI, JANUARY 24, 2008

Earnings JNJ reported 4Q:07 revenues of $15.96 billion, up 17% over the year-ago period and beating consensus estimates of $15.4 billion. Net income was $2.37 billion, or $0.82 per share, missing estimates by $0.04. Depuy reported 4Q:07 sales of $1.21... more

Musculoskeletal News Roundup 10-Jan-08 BY LAUREN UZDIENSKI, JANUARY 10, 2008

M&A ArthroCare Corp. acquired DiscoCare, Inc., whom the company describes as "a third-party billing and reimbursement service provider," for $25 million in cash plus potential future milestone payments. The company says, "This acquisition will allow ArthroCare to significantly expand its... more

Osiris Reports Additional Results from Chondrogen Trial BY LAUREN UZDIENSKI, NOVEMBER 29, 2007

Osiris announced results from an ongoing Chrondogen study this week, with enrolled patients showing less pain and fewer degenerative bone changes when compared to patients receiving HA. Among the highlights: OA patients receiving Chondrogen experienced a statistically significant reduction in... more

Musculoskeletal News Roundup 29-Nov-07 BY LAUREN UZDIENSKI, NOVEMBER 29, 2007

Regulatory Amedica received FDA clearance for their Valeo™ Pedicle Screw system, a low profile and modular pedicle screw system intended for non-cervical pedicle fixation from the T1 through L5. Corin announced FDA clearance for additional sizes of its Cormet hip... more

Musculosketal News Roundup 25-Oct-07 BY LAUREN UZDIENSKI, OCTOBER 25, 2007

Earnings ArthroCare Corp. reported 3Q:07 total revenues of $78.5 million, an increase of 21% over the comparable quarter. Revenues missed estimates by $0.11 million. The company reported net income of $11.1 million, or $0.39 per share, up 28% over 3Q:06... more

JBJS: ACI, Microfracture Show Comparable Outcomes at Five Years BY LAUREN UZDIENSKI, OCTOBER 8, 2007

JBJS published results from a prospective, randomized Norweigan trial where 80 patients were selected to receive either autologous chrondocyte implantation (ACI) or microfracture for the treatment of chronic cartilage defects. There were 40 patients in each group. - Five-year follow-up... more

Musculoskeletal News Roundup 4-Oct-07 BY LAUREN UZDIENSKI, OCTOBER 4, 2007

M&A Orthofix acquired the rights to all of the intellectual property related to the InSWing™ interspinous process spacer. InSWing is designed to relieve pain associated with lumbar spinal stenosis and can be used in a minimally invasive surgical procedure. Orthofix... more

FDA Throws ReGen Biologics Another Curveball BY DAVID KRESSEL, SEPTEMBER 25, 2007

ReGen Biologics today announced it received a "Not Substantially Equivalent" (NSE) letter from the FDA in response to the 510(k) premarket notification the company submitted for its meniscal repair implant. In a press release and conference call, a clearly frustrated... more

Musculoskeletal News Roundup 26-July-07 BY LAUREN UZDIENSKI, JULY 26, 2007

Earnings Stryker reported revenues of $1.46 billion, beating estimates of $1.44 billion and increasing 16% from $1.26 billion in 2Q:06. 2Q:07 earnings were $269.1 million, or $0.65 per share, beating estimates of $0.61 and up from $0.52 in the comparable... more

Musculoskeletal News Roundup 12-July-07 BY LAUREN UZDIENSKI, JULY 12, 2007

M&A Biomet Inc. shareholders accepted an $11.4 billion buyout offer from a private equity consortium attempting to acquire the medical device maker. The consortium, LVB Acquisition LLC, announced Thursday that nearly 83 percent of Biomet's shares were tendered. The company... more

Orthopedic News Roundup 28-June-07 BY LAUREN UZDIENSKI, JUNE 28, 2007

Regulatory Life Spine announced 510(k) clearance for its static anterior cervical plating system Neo®-SL. The system features an integrated lock that allows bone screws to be securely fixated without any additional locking components. The FDA approved new labeling for Genzyme's... more

Amedica Files for $75 Million IPO BY JOHN MCCORMICK, MAY 23, 2007

Yestderday, Utah-based Amedica Corp. filed an initial public offering Securities and Exchange Commission to sell up to $74.75 million in common stock. The company's technology platform is in silicon nitride ceramics as applied to various types of orthopedic implants including... more

Fine-Tuning Computer-Assisted Orthopedic Surgery BY LAUREN UZDIENSKI, MAY 8, 2007

The National Institute of Standards and Technology announced an initiative last week to improve the precision and reliability of computer-assisted orthopedic surgery (CAOS) instruments in hip replacement surgery. NIST researchers have built a "phantom" hip that can be used by... more

Society for Biomaterials a Product Pipeline Crystal Ball BY DAVID KRESSEL, APRIL 24, 2007

Last week, we attended the Society for Biomaterials' annual conference. The event showcases the latest academic research and its broad applications across medical specialties. Roughly a third of the poster presentations focused on orthopedics, and most of the rest related... more

WSJ: Orthopedics a "Hip Bet" BY LAUREN UZDIENSKI, MARCH 6, 2007

Today's Wall Street Journal features an article on growth in the orthopedic market. Journalist Karen Richardson indicates that innovative, long-lasting and high-margin products are driving investment opportunities. An aging population and increased life expectancy bode well for manufacturers like Stryker... more

Orthopedics News Roundup 15-Feb-07 BY LAUREN UZDIENSKI, FEBRUARY 15, 2007

Earnings Tutogen announced results for first fiscal quarter ending December 31, 2006. Total revenues increased 43% to $11.5 million, compared to $8.0 million in the comparable quarter of fiscal year 2006. U.S. revenues increased 50%, and international revenues increased 27%... more

Orthopedics News Roundup 8-Feb-07 BY LAUREN UZDIENSKI, FEBRUARY 8, 2007

Earnings Biologics Regeneration Technologies, Inc. reported 4Q:06 revenues of $19.1 million, down 5% from $20.1 million in 4Q:05. The Company reported net loss of $6.7 million, compared to a net lossn of $1.7 million for 4Q:05. Net loss per diluted... more

Orthopedics News Roundup 1-Feb-07 BY LAUREN UZDIENSKI, FEBRUARY 1, 2007

Earnings Kyphon Inc. announced 4Q:06 sales totaling $112.6 million, an increase of 31% over the $85.8 million in net sales reported for the 4Q:05. Net income for 4Q:06 increased 228% to $12.2 million, or $0.26 per diluted share, compared to... more

Dane Miller to buy Biomet for $10.9 billion: 10 Months to Close BY JOHN MCCORMICK, DECEMBER 18, 2006

This morning Biomet's board of directors announced an agreement to be acquired by Dane A. Miller, the company's longtime CEO who was pushed aside in March of this year. Miller and his backers - a consortium of private equity firms... more

Yet Again, Synvisc Will Not Have To Share Reimbursement Code BY ARIELLA P. GOLOMB, MD, DECEMBER 15, 2006

In October we reported that Genzyme, maker of the viscosupplement Synvisc, announced a CMS decision grouping all industry viscosupplementation products into the same reimbursement code in January 2007. The coding change meant that reimbursement for viscosupplementation treatments will be based... more

Orthopedic News Roundup 30-Nov-06 BY LAUREN UZDIENSKI, NOVEMBER 30, 2006

Earnings ORTHOsoft reported 3Q:06 revenues of CAN $3.8 million (US $3.3 million), up 59% from CAN $2.4 million (US $2.1 million) in 3Q:05. ORTHOsoft manufactures computer aided orthopedic surgery devices, and they attribute the 3Q:06 growth to increased navigation systems... more

Orthopedic News Roundup 2-Nov-06 BY HUYEN NGUYEN, NOVEMBER 3, 2006

Earnings Biologics: Orthovita reported 3Q:06 product sales came in at $11 million, up 32% compared to 3Q:05. Net loss for the quarter was $3.7 million, or a loss of $0.07 per share. The Company beat analysts' EPS estimates by $0.02,... more

Synvisc To Share Reimbursement Code BY ARIELLA P. GOLOMB, MD, OCTOBER 31, 2006

In a press release yesterday, Genzyme, maker of Synvisc, announced a CMS decision that would group all viscosupplementation products into the same reimbursement code in January 2007. The company stated that they would fight hard to dispute this decision (through... more

Orthopedic News Roundup 19-Oct-06 BY HUYEN NGUYEN, OCTOBER 19, 2006

Earnings Dental: Lifecore Biomedical announced that 1Q:07 net sales increased 12% to $15 million. Net income for the quarter was $1.1 million, representing a year-over-year increase of 9%. The Company was in-line with analysts' estimates and reported earnings of $0.08... more

Orthopedic News Roundup 21-Sept-06 BY HUYEN NGUYEN, SEPTEMBER 21, 2006

Earnings: Biomet reported its 1Q:07 earnings totaled $0.44 per share (excluding the adoption of the share-based payment) which was $0.01 more than what analysts were expecting. Revenues increased by 5% to $508 million (foreign currency had a $3 million favorable... more

Orthopedic News Roundup 3-Aug-06 BY HUYEN NGUYEN, AUGUST 3, 2006

Earnings: Biologics: IsoTis OrthoBiologics reported 2Q:06 revenue of $10.8 million, up 43% compared to $7.5 million in 2Q:05. Its U.S. division grew 22%, while international revenues grew 39%. The Company has three distribution channels: U.S. independent agents, international distributors and... more

Exactech's 2Q:06 - A Good Quarter BY HUYEN NGUYEN, AUGUST 2, 2006

On Tuesday, Exactech reported 2Q:06 revenues of $26.6 million, which represents an increase of 11% over 2Q:05. The Company reported $0.18 diluted earnings per share (EPS) and beat analysts' earnings estimates by $0.01. Net income for the quarter was a... more

Orthopedic News Roundup 27-Jul-06 BY HUYEN NGUYEN, JULY 27, 2006

Earnings Results: Biologics: Anika Therapeutics announced 2Q:06 net sales increased 11% to $7.1 million. Product revenues grew 74% while licensing, milestone and contract revenue was down 77%. The large product sales growth was partially driven by higher demand for OrthoVisc®;... more

Orthopedic News Roundup 12-Jul-06 BY HUYEN NGUYEN, JULY 12, 2006

Appointment: Biomet, Inc. appointed Charles E. Niemier as President of EBI's operations following the resignation of its former president, Bart J. Doedens, M.D. Mr. Niemier has been a member of the senior management team and Board of Directors for more... more

Orthopedic News Roundup 29-Jun-06 BY HUYEN NGUYEN, JUNE 29, 2006

Appointment: Spine Wave announced that it has elected Ron Pickard to its Board of Directors. In addition to his role on the Board, Mr. Pickard will be actively involved in key projects including the development and commercialization of Spine Wave's... more

Smith & Nephew and Q-MED Form Hyaluronic Acid Treatment Alliance BY ARIELLA P. GOLOMB, MD, JUNE 28, 2006

Viscosupplementation to treat osteoarthritis has traditionally been performed with a course of three or five injections. Today Smith & Nephew Inc. and Q-MED AB announced an alliance which paves the way for the US marketing of DUROLANE, the first and... more

Biomet Also Receives Subpoena BY JOHN MCCORMICK, JUNE 26, 2006

This morning, Biomet announced that it has a subpoena from the Department of Justice, Antitrust Division, requesting documents regarding possible violations of federal criminal law, including possible violations of the antitrust laws, relating to the manufacture and sale of orthopedic... more

Zimmer Gets Dept. of Justice Subpoena BY JOHN MCCORMICK, JUNE 26, 2006

Zimmer Holdings Inc. said Friday the Justice Department's antitrust division subpoenaed company documents pertaining to an investigation of possible violations of federal criminal law, including possible violations of antitrust laws, involving the manufacture and sale the Company's standad lines of... more

1Q:06 Preliminary Earnings Summary BY HUYEN NGUYEN, APRIL 27, 2006

The first group of orthopedic companies reported their 1Q:06 this week and took in $5.3 billion so far. The total aggregated revenues for the quarter were up by 7% from $4.9 billion in 1Q:05. The industry netted $637.8 million, a... more

Orthopedic News Roundup 20-Apr-06 BY HUYEN NGUYEN, APRIL 20, 2006

Many orthopedic companies will be reporting their 1Q:06 results in the next few weeks. The table below provides a listing of conference call dial-in numbers and webcasts for the investment community. How the overall orthopedic industry fared in the first... more

Ossur Product Recall BY HUYEN NGUYEN, APRIL 4, 2006

Last week Ossur announced product recall on one of its prosthetic knee lines. The Total Knee® 1100, 1900, 2000 and 2100 models were being recalled due to some faulty pins that were fixated at the axis of the knee. The... more

A Surgeon's Look at Costs In Total Joint Arthroplasty BY LAING RIKKERS, MARCH 31, 2006

One of the most informative sessions at AAOS was a section of the Health Policy Update Symposium delivered by William L. Healy, M.D. of the Lahey Clinic. Healy gave real-life examples of the complicated and delicate balance of hospital economics,... more

Orthopedic News Roundup 30-Mar-06 BY HUYEN NGUYEN, MARCH 30, 2006

Dane Miller of Biomet called it quits a week after releasing its 3Q:06 earnings report. Last week, the Company reported earnings per share (EPS) of $0.43 which was in line with Street's estimate but did not meet analysts' expectation for... more

Dane Miller to Retire BY JOHN MCCORMICK, MARCH 27, 2006

This morning, legendary orthopedic CEO, Dane A. Miller, Ph.D., Biomet's President and Chief Executive Officer and co-founder, announced his decision to retire. He will remain a Director and serve as a consultant. The Biomet Board has appointed Senior Vice President... more

2006 Orthopedic Industry Forecast - Strong Growth to Continue BY EDITOR, MARCH 21, 2006

Our current forecast for the orthopedic industry projects continued long term growth of 15%. For 2006, we expect growth to be slightly below this trend, at 12%. Despite continued strength in other segments of the industry, hip and knee reconstruction... more

Scientific Advisory Board AAOS Sessions BY JOHN CHOPACK, MARCH 16, 2006

In addition to the Top Sessions we chose, we have added AAOS presentations by our Scientific Advisory Board members. Please click on the link at the bottom to view the entire list. Wednesday, March 22 10:30 AM - 12:30 PM127Changing... more

Ceramics Getting Stronger? BY JOHN MCCORMICK, MARCH 15, 2006

Developments in ceramics has always been of great interest to participants in our industry. We thought we would alert you to this article in Wired Magazine that summarized some recent findings in ceramic technology. In essence, scientists are finding that... more

Our Top Picks -- AAOS 2006 Educational Sessions BY JOHN CHOPACK, MARCH 14, 2006

With the AAOS in Chicago fast approaching, we have put together a list of "Hot Sessions" to check out. Please click on the link at the bottom to view the entire list. Adult Reconstruction, Hip and KneeSunday, March 26, 2006... more

Analyst Meetings during AAOS BY KAREN FEDER, FEBRUARY 23, 2006

Looking ahead to the AAOS 73rd Annual Meeting on March 22-26, 2006 taking place at the McCormick Place Convention Center in Chicago, we wanted to post the latest information on Company Analyst meetings that will be held in Chicago: -... more

Orthopedic News Roundup 23-Feb-06 BY LAING RIKKERS, FEBRUARY 23, 2006

Financing: BioMimetic Therapeutics, Inc. filed a registration statement for an Initial Public Offering. Earnings: Medtronic 3Q Earnings climb 23 percent. CryoLife fourth quarter 2005 revenues increased 13% over fourth quarter 2004 Gross margins for full year 2005 increased to 53%... more

Wright Medical's Forecast Disappoints BY DAVID KRESSEL, FEBRUARY 10, 2006

Last night Wright (WMGI) reported slightly better than expected results, but lowered 2006 guidance dramatically. Revenue guidance dropped modestly, but EPS guidance was knocked down substantially because Wright will increase investments in R&D and sales and marketing. 2006 Guidance, and... more

Smith & Nephew Reports 15% Growth in Orthopedics BY DAVID KRESSEL, FEBRUARY 10, 2006

Smith & Nephew reported results for 4Q05 and FY2005, and they were strong particularly within their Orthopedics segment. For the quarter, they saw 15% growth (ex F/X) in orthopedic sales to $1,267 million, which broke down as follows: *Knees: +12%... more

Insiders Buying Stryker's Shares (EDITORIAL) BY JOHN MCCORMICK, NOVEMBER 3, 2005

It has never been empirically proven that insider (e.g. management and director) buying of a company's stock guarantees that the stock poised to rise, but it has also never been proven to be a bad sign. That's stating the obvious.... more

Orthopedic News Roundup 27-Oct-05 BY HUYEN NGUYEN, OCTOBER 27, 2005

It has been a busy week for many CEOs and CFOs in the orthopedic device sector. In the past two weeks orthopedic companies reported 3Q:05 sales of $4.7 billion which was a 12% increase over the 3Q:04. Net earnings for... more

Implant Pricing: Not Black and White (EDITORIAL) BY JOHN MCCORMICK, OCTOBER 21, 2005

Is Wall Street's shrill reaction to hip and knee implant pricing concerns overblown? Even with sophisticated econometric tools such a question is difficult to evaluate because we are dealing with an expectations driven phenomenon. So we have our doubts about... more

Orthopedic News Roundup 06-Oct-05 BY HUYEN NGUYEN, OCTOBER 6, 2005

While Medtronic was the big winner this week, Wright Medical ("WMGI") captured more headlines with two important news items that have negatively impacted their stock price. On Wednesday, WMGI's stock price suffered a huge loss with 20% decline intraday due... more

A Follow-Up Interview with Gerald 'Gary' Bisbee, CEO of ReGen Biologics, Inc. BY JOHN MCCORMICK, OCTOBER 6, 2005

One of the leaders in this emerging meniscus repair market is ReGen Biologics. We recently had a chance to do a catch up with Gary Bisbee, CEO of ReGen Biologics who we interviewed last year. Disclosure: Individual members of HealthpointCapital,... more

Orthopedic News Roundup 29-Sept-05 BY HUYEN NGUYEN, SEPTEMBER 29, 2005

It's all about spine this week. With NASS in full swing in Philadelphia, many companies eagerly issued press releases during the conference. Clinical: Cervical-Stim® is a post-operative cervical brace that generates a uniformed, low-level pulsed electromagnetic field (PEMF) at the... more

Orthopedic News Roundup 29-Sept-05 BY HUYEN NGUYEN, SEPTEMBER 29, 2005

It's all about spine this week. With NASS in full swing in Philadelphia, many companies eagerly issued press releases during the conference. Clinical: Cervical-Stim® is a post-operative cervical brace that generates a uniformed, low-level pulsed electromagnetic field (PEMF) at the... more

ReGen Biologics Update: FDA Warning Letter BY JOHN MCCORMICK, SEPTEMBER 25, 2005

On Friday ReGen Biologics, Inc. reported that it received a warning letter dated September 16, 2005 from the FDA. The warning letter was a follow-up to the FDA Form 483 notice of inspectional observations received by ReGen and, along with... more

Orthopedic News Roundup 5-Aug-05 BY HUYEN NGUYEN, AUGUST 5, 2005

This week we finish off the first half of 2005 reporting season with 17 orthopedic companies* released their financial numbers. In 2Q:05, in an aggregated total, orthopedic revenues increased 16% ($3.8 billion vs. $3.2 billion) and a 25% increased in... more

Orthopedic News Roundup 29-Jul-05 BY HUYEN NGUYEN, JULY 29, 2005

Earnings: Please refer to the table (below) for individual company sales and earnings. It's all about earnings this week... Biologics: Clearly, the big winner this week is LifeCell Corp. who reported strong earnings on Monday stock was up 24% at... more

Biomet Revises 4Q:05 Earnings Guidance Downward BY JOHN CHOPACK, JUNE 21, 2005

Biomet announced last evening that it was reducing its 4Q:05 earnings guidance as a consequence of hitting the low end of its previous range for 4Q:05 revenues. The Company stated that revenues totaled $503 million for the 4Q:05 which is... more

1Q:05 Large Joint Review: Knees Remain Strong while Hips Weaken BY JOHN CHOPACK, MAY 9, 2005

With most of the major large joint market share leaders reporting their 1Q:05 financials, we examine the strength of the market. At first glance revenue growth of hip products seems to be slowing while knee growth accelerates. Hips We estimate... more

Zimmer (ZMH:NYSE) Crushes the Street - Again. BY JOHN CHOPACK, MAY 2, 2005

During the 4Q:04 Zimmer beat analyst expectations by $0.07 in earnings-per-share and $18 million in revenues. For their encore, Zimmer reported 1Q:05 adjusted earnings-per-share (diluted) of $0.75 and revenues of $829 million which was exceeded analysts' forecasts by $0.08 and... more

Wright Medical (WMGI:NASDAQ) Reports 1Q:05 BY JOHN CHOPACK, MAY 2, 2005

Wright reported 1Q:05 revenues of $82.6 million which was a 10% increase over the 1Q:04. Excluding the effect of currency, WMGI revenues increased 9%. The 10% growth in revenues was almost 3% slower than the revenue growth reported during the... more

Stryker Corp. (SYK:NYSE) Reports 1Q:05 Financials; Beats the Street by $0.02 BY JOHN CHOPACK, APRIL 25, 2005

SYK reported 1Q:05 revenues of $1.2 billion which was a 16% increase over the 1Q:04 and beat analyst expectations by $2 million. The Company reported earnings of $0.42 per diluted share which was $0.02 better than analyst were forecasting. The... more

Elderly Population: New Census Bureau Forecast BY JOHN MCCORMICK, APRIL 25, 2005

Last Thursday the US Census Bureau released new state-by-state projections on the aging of the U.S. population which showed not only how it expects the nation to age, but how the population is expected to shift geographically over the next... more

Gain-Sharing: The Lawyers View BY JOHN CHOPACK, APRIL 18, 2005

Background on Gain Sharing. The Hospital Corporation of America ("HCA") has recently asked the Office of Inspector General ("OIG") of the Department of Health & Human Services ("HHS") to allow for "gain-sharing" arrangements. These gain-sharing arrangements would allow hospitals to... more

Corin Group PLC (CRG.LN) Reports a 20% Increase Net Profit in FY2004 BY HUYEN NGUYEN, APRIL 18, 2005

On April 5th, Corin reported fiscal year 2004 financial results. Total sales grew by 9% on a constant currency basis and 7% as reported. Group turnover for the year was reported at £25.6 million, compared to £24 million in 2003.... more

The Industry Subpoenaed: Our Perspective BY JOHN MCCORMICK, APRIL 4, 2005

The healthcare industry has long been the subject of regulation by complex laws that do not exist in other industries and which, under certain circumstances, may seem almost excessive and counter-intuitive. The enforcement of these laws has been significant and... more

Preservation of Motion in the Lumbar Spine: A Trip Report BY JOHN MCCORMICK, MARCH 21, 2005

At the end of last week, we attended the University of South Florida's "Preservation of Motion in the Lumbar Spine" course to check in on how leading surgeons are coming along with motion preserving spinal procedures and related surgical implant... more

What Price Innovation? | EDITORIAL | BY JOHN MCCORMICK, MARCH 21, 2005

I was struck by economist Paul Krugman's article "America's Senior Moment" in the most recent New York Review of Books. In the article Krugman assails the Bush Administration's push for social security "privatization" with the fervor of a campus radical,... more

4Q:04 Orthopedic Wrap-up BY JOHN CHOPACK, MARCH 14, 2005

We have aggregated the 4Q:04 and 3Q:04 reported revenues (includes the effects of foreign currency) for 16 public orthopedic companies. Although we would have liked to use revenue growth rates which excluded foreign currency, a majority of the companies report... more

Exactech (EXAC:NASDAQ) Reports 4Q:04 Financials which were slightly below Analyst Expectations BY JOHN CHOPACK, MARCH 7, 2005

EXAC reported revenues of $21.3 million during the 4Q:04 which was a 14% increase over the 4Q:03 but was $300 thousand below analyst's expectations. Earnings-per-share on a diluted basis totaled $0.17 which was also slightly below analyst expectations of $0.16.... more

Encore Medical (ENMC:NASDAQ) Reports 4Q:04 and 2004 Year-end Results BY JOHN CHOPACK, MARCH 7, 2005

From a business development and strategy execution standpoint/2004 was an excellent year for Encore. Management completed two acquisitions (Empi and Osteoimplant Technologies, Inc.) which fits the overall business development strategy of ENMC: growth via acquisition. The acquisitions helped drive revenues... more

2005 AAOS: Louder, Yet Quieter than Ever Before BY JOHN CHOPACK, MARCH 1, 2005

The 2005 American Academy of Orthopaedic Surgeon Annual Conference was unique to recent meetings. It was louder in terms of the amount of marketing, size of exhibits and mass advertising, yet it was quieter in terms of business development and,... more

2005 AAOS Analyst Meeting Reviews BY JOHN CHOPACK, MARCH 1, 2005

This year we attended Smith & Nephew's, Biomet's, Stryker's, and Encore Medical's analyst meetings. All were very professional and well attended. Here are our notes from each: Smith & Nephew Overview: Although Smith & Nephew posted the best large joint... more

FIVE HOT AAOS Sessions Plus 20 others worth a close look BY EDITOR, FEBRUARY 22, 2005

Overwhelmed with all the education opportunities? Join the club. Good news for you, though - the HealthpointCapital research team has whittled down the program to 26 of the most controversial and best-hosted side sessions. Minimally Invasive Breaks Out Every year... more

2005 American Academy of Orthopaedic Surgeons (AAOS) Preview BY JOHN CHOPACK, FEBRUARY 14, 2005

It's here again, the annual AAOS conference. Thousands are ready to descend on Washington, D.C. the week of February 21st to learn of new surgical techniques, new products and to develop business and relationships. While it is hard to predict... more

Wright Medical (WMGI:NASDAQ) Reports 4Q:04 Financials BY JOHN CHOPACK, FEBRUARY 14, 2005

Wright reported both 4Q:04 and year-end 2004 financials on Thursday evening. 4Q:04 revenues totaled $77.7 million a 13% increase over 4Q:03 revenues and at the upper end of management's previous guidance of revenues of $76-$78 million. Revenues for the year... more

Smith & Nephew (SNN:NYSE) Reports 4Q:04 & 2004 Financials BY JOHN CHOPACK, FEBRUARY 7, 2005

After a strong report from Zimmer earlier in the week, Smith & Nephew followed suit on Thursday. SNN reported revenues totaled £332 million for the 4Q:04 which was a 14% increase over the 4Q:03 on a constant currency basis. Earnings-per-share... more

Zimmer (ZMH:NYSE) Beats the Street by $0.07 in EPS and $18 Million in Revenues; Stock Gains 11% on Tuesday. BY JOHN CHOPACK, FEBRUARY 7, 2005

After Stryker and DePuy reported somewhat modest financial reports two weeks ago, it seemed like many industry analysts and experts were talking of a potential slowdown in orthopedic growth. Then Zimmer reported revenues of $800 million for the 4Q:04 which... more

Stryker Corp. (NYSE:SYK) Reports 4Q:04 and 2004 Financials BY JOHN CHOPACK, JANUARY 31, 2005

Stryker reported 4Q:04 revenues of $1.156 billion which was an increase of 15% on a reported basis over the 3Q:04. This was slightly below analyst expectations of $1.158 billion in revenues. Earnings for the 4Q:04 totaled $0.40 per diluted share... more

Johnson & Johnson (NYSE:JNJ) Reports 4Q:04 Results: We Examine DePuy's Charite BY JOHN CHOPACK, JANUARY 31, 2005

JNJ reported revenues of $12.8 billion for the 4Q:04 which was a 13% increase over the 4Q:03. DePuy, JNJ's orthopedic division, reported revenues of $952 million for the 4Q:04. This was a 19% increase as reported and a 15% increase... more

Direct-to-Consumer Advertising Takes Hold in Orthopedics | EDITORIAL | BY JOHN CHOPACK, JANUARY 24, 2005

Direct-to-consumer advertising has become the most powerful means of marketing pharmaceuticals over the last decade. For years we have seen these strange advertisements which typically only mention the name of a drug and the manufacturer, but withhold any information regarding... more

Biomet (BMET:NASDAQ) Reports 2Q:05 Adjusted Earnings of $0.38 which is In-line with Analyst's Expectations. BY JOHN CHOPACK, DECEMBER 20, 2004

BMET reported adjusted earnings-per-share of $0.38 during the 2Q:05 which was a 19% increase over the 2Q:04. The adjusted earnings do not include certain non-recurring costs associated with the acquisition of Merck KGaA's interest in Biomet Merck and the acquisition... more

Wright Medical Holds Annual Analyst Guidance Call - The Future is Bright BY JOHN CHOPACK, DECEMBER 13, 2004

Wright Medical (WMGI:NASDAQ) held its annual analyst guidance call to provide management's outlook for sales, earnings and product trends for the 4Q:04, year-end 2004/2005 and 2006. The forecasts, we think, look strong: 4Q:04 - The Company has reaffirmed its October... more

VIOXX Wars Good News for Large Joint Reconstruction Market BY ROBIN R. YOUNG CFA, NOVEMBER 29, 2004

The lawyer's ads are all over the country and all over the two broadest media outlets we know - television and the internet. "Learn about Vioxx, the Vioxx recall and potential health risks!" "Are you a Vioxx Patient? Find out... more

Smith & Nephew (SNN:NYSE) Reports Strong 3Q:04 Financials BY JOHN CHOPACK, NOVEMBER 8, 2004

Smith & Nephew reported revenues of '288.9 million for the 3Q:04 which was a 12% increase over the 3Q:03 on a constant currency basis. Earnings for the 3Q:04 totaled '4.99p per share which was a 15% increase over the 3Q:03.... more

Encore Medical (ENMC:NASDAQ) Reports 12% Sales Growth in 3Q:04 BY JOHN CHOPACK, NOVEMBER 8, 2004

Encore reported its 3Q:04 financials on Monday of last week. Revenues totaled $30.6 million which was a 12% increase over 3Q:03. Earnings totaled $0.04 (excluding certain non-recurring expenses) which was a $0.01 higher than analysts were anticipating and a significant... more

Exactech (EXAC:NASDAQ) Reports 15% Revenue Increase for 3Q:04 / Misses Analyst Consensus Estimates BY JOHN CHOPACK, NOVEMBER 3, 2004

Exactech reported net revenues of $19.5 million for the 3Q:04 which was a 15% increase over the 3Q:03, but slightly below analyst expectations of $20 million. Earnings totaled $0.14 per diluted share which was a 20% increase from the 3Q:03... more

Zimmer Holdings (ZMH:NYSE) Reports $700 million in 3Q:04 Sales, up 13% (10% constant currency) BY JOHN CHOPACK, NOVEMBER 3, 2004

Zimmer also beat earnings expectations by $0.03 per share. Hip revenues rose 14%, knees revenues were up 16% but spine declined 2%. These percentages were as reported. We give the constant currency numbers later in this note. Guidance for the... more

Wright Medical (WMGI:NASDAQ) Reports 28% biologics growth and 23% Hip growth in 3Q:04 BY JOHN CHOPACK, NOVEMBER 3, 2004

Wright Medical reported a blistering 28% rate of growth for its biologics products as well as a solid 23% rate of revenue growth for its hip products. Clearly, this is a company that is gaining market share from biomaterials. Hip... more

The 3Q:04 Earnings Season is Half-way Completed for Large Joint Manufacturers: Any Trends? BY JOHN CHOPACK, OCTOBER 25, 2004

Three of the seven leading large joint orthopedic manufacturers have reported their 3Q:04 financials. So far, market growth rates on a constant currency basis remain in-line with the growth rates reported by industry leaders DePuy, Biomet and Stryker in the... more

VIOXX: Systemic Problems Doom Another Systemic Drug BY ROBIN R. YOUNG CFA, OCTOBER 4, 2004

Since its introduction, more than 91 million prescriptions for VIOXX have been written in the United States for patients with arthritis pain in either the hip or knee. If one were to include all the prescription Cox-2 inhibitor drugs like... more

Wright Medical (WMGI: NASDAQ) Lowers 3Q:04 Earnings Guidance by $0.04 BY JOHN CHOPACK, SEPTEMBER 27, 2004

WMGI announced that it was lowering its previous earnings per share guidance of $0.13-$0.15 to a range of $0.09-$0.11, or approximately $3.2 - $3.9 million. However, the Company maintained its current revenue projections for the 3Q:04 of $68 - $70... more

Biomet (BMET: NASDAQ) Beats Analyst's 1Q:05 Earnings Expectation by $0.01 Per Share BY JOHN CHOPACK, SEPTEMBER 20, 2004

BMET reported adjusted earnings of $0.36 which excluded the acquisition of Biomet Merck joint venture and Interpore International. This was an increase of 20% over the 1Q:04 and $0.01 better than consensus estimates. However, BMET's revenues of $438 million, which... more

Hip Net Revenue Growth Rate Slows During 2Q:04, But Knees Accelerate BY JOHN CHOPACK, SEPTEMBER 20, 2004

After the dust cleared from the 2Q:04 earnings season and we had time to analyze the large joint reconstruction market, it was clear that a cursory glance at the market showed a declining revenue growth rate in the hip market... more

Smith & Nephew (SNN:NYSE) Reports 14% Rise in Orthopedic Revenues 21% Increase in U.S. Knee Sales BY JOHN CHOPACK, AUGUST 16, 2004

Smith & Nephew reported an 8% increase in revenues which totaled '350 million for the 2Q:04. Orthopedics was the strongest segment of SNN, increasing by 14% worldwide and 18% in the US. Growth in Endoscopy sales rebounded from flat to... more

Encore Medical (ENMC:NASDAQ) Reports Revenues Totaled $29.3 Million for the 2Q:04; Analyst were Expecting $30.4 Million BY JOHN CHOPACK, AUGUST 16, 2004

The slight miss in net revenues combined with missing analyst EPS expectations by $0.01 ($0.04 reported versus a $0.05 estimate) sent shares of ENMC downward by 23% on Monday. Encore follows Stryker, Exactech, Wright, and Zimmer who have all seen... more

Zimmer Beats the Street by $0.03 in EPS and $4 Million in Revenues; Stock Sells Off 13% in Intraday Trading BY JOHN CHOPACK, AUGUST 16, 2004

It is like a broken record; another solid orthopedic earnings report and investors dump shares, again. In similar fashion to Stryker, Exactech and Wright Medical, Zimmer (NYSE: ZMH) beat analysts earnings expectations and investors reacted by selling shares. The difference... more

Zimmer Holdings (ZMH:NYSE) Reports 2Q:04 Earnings - Beats the Street and Sells Off BY JOHN CHOPACK, AUGUST 2, 2004

It seems that orthopedic investors have it in their mind this earnings season that unless a company crushes its numbers and guides significantly to the upside, they will dump shares. This happened to Stryker, Exactech and Wright Medical and now... more

Wright Medical Reports a 22% Increase in Revenues and a 34% Increase in Earnings; Stock is Off as Much as 16% on Wednesday BY JOHN CHOPACK, AUGUST 2, 2004

In a common trend this earnings season, Wright Medical reported in our opinion one of the best second quarters of 2004 in the orthopedic sector and investors congratulated the Company by dumping shares. Wright Medical is one of four large... more

Exactech (EXAC:NASDAQ) Reports Solid 2Q:04 - 15% Increase in Revenues & Earnings BY JOHN CHOPACK, JULY 26, 2004

EXAC reported revenues of $20.4 million which was a 15% increase over revenues of $17.8 million during the 2Q:04. The Company also reported net income of $1.6 million or $0.16 per diluted share, which represented a 15% increase over the... more

We Pause to Examine the Large Joint Market Ahead of the Conclusion of Earnings Season BY JOHN CHOPACK, JULY 19, 2004

With DePuy, Stryker and Biomet reporting during the last three weeks, this is a good time to identify specific topics imperative to the remainder of the sector's earnings releases over the next several weeks. Large Joint Companies Earnings 2Q:04 Reports... more

Hospitals Push Back on Future Price Increases BY ROBIN R. YOUNG CFA, JULY 19, 2004

In 1995 the average coated femoral stem cost $2,458. Today, coated femoral stems range from $4,225 to $5,097 each for an 85% price increase in 9 years. As we demonstrate in the following table, the rate of component price increases... more

Stryker Corp. (SYK:NYSE) 2Q:04 Earnings Increase by 42%which Beats the Street by $0.03 BY JOHN CHOPACK, JULY 19, 2004

SYK reported earnings totaled $152.7 million or $0.37 per diluted share during the 2Q:04. This 42% increase over the 2Q:03 beat analyst expectations by $0.03. It also triggered several analyst downgrades including First Albany, Wells Fargo and Bank of America.... more

Biomet (BMET:NASDAQ) Beats the Street by $0.01 in EPSand $16 Million in Revenues BY JOHN CHOPACK, JULY 12, 2004

Biomet announced that revenues totaled $447 million for the 4Q:04 and $1.6 billion in 2004 representing a 19% and 16% increase, respectively. Adjusted earnings (for the acquisitions of Merck Joint Venture and Interpore Cross) per share totaled $0.37 for the... more

Current Concepts in Joint Replacement (CCJR) BY JOHN CHOPACK, JUNE 7, 2004

Current Concepts in Joint Replacement (CCJR) is the best conference for hip, knee and shoulder reconstruction. The meeting allows for surgeons to present new data, debate topics and demonstrate new techniques via live surgery. Our major take-away is that surgeons... more

It's About Time! Mobile-Bearing Knee Is Headed for a Down Classification BY JOHN CHOPACK, JUNE 7, 2004

On Wednesday of last week, (June 2/2004) an FDA panel recommended to down classify both the tricompartmenal and unicompartmental mobile bearing knee by a vote of 6 to 2 and 5 to 3, respectively. Although this doesn't guarantee that the... more

CMS Proposes New Reimbursement Rates - DRG 209 Rate Increases by 2% BY JOHN CHOPACK, MAY 24, 2004

Center for Medicare and Medicaid Services (CMS) released its 2005 proposed payments for inpatient procedures on May 18th/2004. CMS is calling for a 2% increase in DRG 209 payments bringing the total payment to $10,034 up from $9,839 the year... more

A Review of the Five Largest Orthopedic Companies' 1Q:04 Financial Results BY JOHN CHOPACK, MAY 17, 2004

We tabulated the five largest general orthopedic companies' financial results for the 1Q:04. The companies include Stryker, Zimmer, Biomet, Smith & Nephew and Wright Medical, each of which has a market capitalization in excess of $1 billion. Although many subscribers... more

Smith & Nephew Reports Strong 1Q:04 Financials Driven by Further Penetration of Oxinium Sales BY JOHN CHOPACK, MAY 10, 2004

Sir Christopher O'Donnell, CEO of Smith & Nephew, held an analyst call to discuss the Company's progress throughout the first 90 days of 2004. The Company reported revenues of '302 million which was a 12% increase in underlying sales growth... more

Kyocera Corporation and Kobe Steel Collaborate to Form #1 Japanese Orthopedics Company BY ROBIN R. YOUNG CFA, MAY 3, 2004

Ranking, respectively #1 and #2 among Japanese orthopedics companies - but lagging behind American and UK firms (who hold, we estimate, the top 5 positions in the Japanese market) - the medical products businesses of Kyocera and Kobe Steel have... more

Zimmer's Management Takes 2 Hours out of their Schedule to Discuss Both Its Operational Results and Status of the Orthopedic Market BY JOHN CHOPACK, MAY 3, 2004

Zimmer reported its 1Q:04 financial results on Monday evening and on Tuesday morning held a 2 hour and 15 minute conference call with industry analysts to discuss its results. Although some analysts may believe that 2 hours is too long... more

Exactech Reports a 16% Increase in 1Q:04 Revenues BY JOHN CHOPACK, MAY 3, 2004

Exactech (EXAC:NASDAQ) announced that revenues totaled $21 million during the 1Q:04 which was a 16% increase over the 1Q:03. Knee sales, which accounted for approximately 60% of 1Q:04, increased by 21% over the same period a year. The Optetrak knee... more

Wright Medical's Hip Sales Increase 52% In Quarter. Ceramic-On-Ceramic and Metal Bearings The Key. BY JOHN CHOPACK, MAY 3, 2004

Wright Medical (WMGI:NASDAQ) reported that revenues totaled $74.9 million during the 1Q:04 which was a 28% increase (22% on a constant currency basis) over the 1Q:03. WMGI also reported that $6.6 million of these revenues flowed through the P&L to... more

Corin Group PLC Increases Sales by 39% by Targeting Baby Boomer Patient Population BY JOHN CHOPACK, APRIL 19, 2004

While it is widely accepted that the baby boomer population will have a significant impact on the overall orthopedic industry, we believe that the Corin Group, located in the UK, has developed a unique product offering to address this younger,... more

Stryker Corp & DePuy Report 1Q:04 Earnings and Provide Insight into Strength of Large Joint Reconstructive Market BY JOHN CHOPACK, APRIL 19, 2004

DePuy and Stryker Corp. both reported their 1Q:04 earnings during the last week of trading activities. This provided some insight into both the strength of the Large Joint Orthopedic market and how the additional orthopedic companies will report during the... more

A Random Walk Down the Academy's Halls BY JOHN CHOPACK, MARCH 22, 2004

Stryker Corp. (SYK:NYSE), in similar fashion to last year, brought and introduced a majority of its operational leaders of its various operating divisions. However, a significant portion of the analyst meeting, especially Q&A, centered around Stephen MacMillan, President & COO,... more

The 2004 AAOS Whirlwind BY JOHN CHOPACK, MARCH 22, 2004

The 2004 American Academy of Orthopedic Surgeons hit with the speed and intensity of a tornado. It wasn't a destructive tornado but rather a whirlwind of innovative technology and merger activity. Biomet (BMET:NASDAQ) couldn't wait for the official Academy to... more

Encore Medical Turns It Around in 2003 BY JOHN CHOPACK, MARCH 8, 2004

Encore (ENMC) management reported revenues of $27.9 million and $108.1 million during the 4Q:03 and 2003, respectively. This represented a 6% and a 13% increase over 4Q:02 and 2002 revenues. In our opinion, the most important revenue turn around during... more

The Machine Keeps Rolling - Zimmer Beats the Street, Again BY JOHN CHOPACK, FEBRUARY 23, 2004

The 4Q:03 conference call offered the first glimpse into how Zimmer's (NYSE:ZMH) integration of Centerpulse was progressing. Ray Elliott, CEO of the “New Zimmer”, offered some insights. Zimmer currently has “100 fulltime employees managing 250 major integration projects and 1,700... more

Exactech Reports 2003 Financials – Revenues Increase by 20% Driving a 22% Increase in Net Income BY JOHN CHOPACK, FEBRUARY 23, 2004

Exactech reported that 2003 revenues totaled $71.3 million, an increase of 20% over 2002. Knee sales, which now total 57.4% of sales, increased by 23% to $41.3 million during the 4Q:02. Hips had a disappointing 2003, as they increased by... more

Wright Medical – Best Company in Orthopedics? BY JOHN CHOPACK, FEBRUARY 23, 2004

For the just completed quarter and year, Wright Medical (NASDAQ:WMGI) reported, we believe, the best quarter and year in orthopedics. First, Wright's seven year investment in the Investigational Device Exemption (IDE) ceramic-on-ceramic clinical hip trial delivered huge dividends in 2003.... more

Smith & Nephew Reports Orthopedic Revenues Total $867 Million , Up 16% from 2003 BY JOHN CHOPACK, FEBRUARY 9, 2004

Smith & Nephew (SNN) reported that revenues totaled $1.9 billion during 2003 which was an 11% increase in underlying sales over 2002. Underlying orthopedic revenues increased by 16% during 2003, totaling $867 million. The Orthopedic growth of 16% was 7%... more

Down Classification of Mobile Bearing Knee for Total Knee Arthroplasty Commentary BY JOHN CHOPACK, FEBRUARY 2, 2004

Currently, DePuy is the only orthopedic manufacturer FDA approved to market a mobile bearing knee in the U.S. While a majority of manufacturers market their mobile knee prosthesis overseas, most have been content on waiting for the FDA to down... more

Stryker Corp Reports 21% Sales Rise in 4th quarter BY JOHN CHOPACK, FEBRUARY 2, 2004

Stryker (SYK) reported that revenues totaled $1.1 billion in 4Q:03 and $3.63 billion for the full year 2003. This represented a 21% and a 20% increase over the respective periods last year. The increase in revenues helped drive a 27%... more

It's Almost Routine – Zimmer Crushes Analysts' Consensus Estimates... Again BY JOHN CHOPACK, JANUARY 26, 2004

Zimmer reported an abridged 4Q:03 financial report last week along with updated guidance for 2004. While many investors have come to expect Zimmer to exceed analyst expectations, we thought the 4Q:03 could represent the most difficult challenge for the Company... more

Smith & Nephew posts 16% ortho revenue growth (+23% in knees!) BY EDITOR, DECEMBER 22, 2003

Smith & Nephew (SNN:NYSE) held a trading update conference call on Thursday to provide an update on its performance during the 2H:03 – which at 16% orthopedic growth is in-line with the respective market. However, SNN's knee growth rate of... more

Biomet Reports 14% Sales Increase BY EDITOR, DECEMBER 22, 2003

Biomet (BMET:NASDAQ) reported its 2Q:04 financials on Thursday. As a consequence of not reporting financials based on a calendar fiscal year, BMET is the earliest to report their quarter. Therefore, both analysts and orthopedic investors pay close attention to BMET... more

Wright Medical - Growing for the Long Run BY EDITOR, DECEMBER 15, 2003

Guidance to 2005? This is a famously conservative management, so to guide out to 2005 is cause to sit up and take notice. What's going on at Wright medical? Strong biologics and ceramic on ceramic hip components certainly. But, we... more

Conference Focus on Materials BY EDITOR, NOVEMBER 24, 2003

At the 78th annual reunion of the Société Française de Chirurgie Orthopédique et Traumatologique (SO.F.C.O.T.) held last week in Paris, the focus was clearly on new materials - ceramics, plastics and biologics. And among the most successful new materials companies... more

The Krispy Kanary in the Orthopedic Mine is singing BY EDITOR, NOVEMBER 24, 2003

Like much of orthopedics, Krispy Kreme sells a lifestyle product. And the basic emotion encompassed in that product is comfort. For eighty five cents, Krispy Kreme delivers a nearly perfect, melt in your month donut and, with that, a happy,... more

Merrill Lynch downgrades Smith and Nephew BY EDITOR, NOVEMBER 24, 2003

About a year ago, Merrill downgraded the entire orthopedics industry saying that revenue growth rates were about to moderate from 2002's blistering 14% growth rates. Medicare was the proximate reason. Unfortunately (for Merrill) orthopedic revenues accelerated in 2003 to 18%... more

Smith and Nephew merge with Stryker? BY EDITOR, NOVEMBER 5, 2003

Earlier today, Reuters published a short story recounting an occasional rumor that Smith & Nephew (SNN) and Stryker (SYK) are in merger discussions. It is a rumor and may very well prove false, but the logic is strong. Here's our... more

Encore Prints More Money BY EDITOR, NOVEMBER 3, 2003

There are two ways to print money if you are a private citizen; counterfeit it – and we all know where that leads – or print stock certificates. Encore announced that it intends to print another 7 million shares. That... more

Of Zoomers, Boomers and Macaroomers BY EDITOR, SEPTEMBER 29, 2003

The data we see coming from the Centers for Medicare and Medicaid (CMS) tells us that the large joint reconstruction market is being driven by people born before 1944. Not Boomers. Not Zoomers – whatever they are – or any... more

In a testament to second chances, InFUSE gets CMS approval for $8,900. BY EDITOR, AUGUST 4, 2003

Rejected one year ago... Medtronic came back with new data and CMS, while rejecting InFuse again using one analytical approach found another way to show that InFUSE does indeed meet the threshold requirement for receiving a new technology add-on payment.... more

Zimmer, Regeneration and Kyphon Leave Analysts Reeling. The others are merely excellent. BY EDITOR, JULY 28, 2003

Zimmer: There is no doubt in our mind that Zimmer is grabbing market share – quickly. It is clear that MIS at Zimmer is bigger than instruments and implants; it is really about (aside from improving patient outcomes) reimbursement. CEO... more

Stryker adds $107 million in new orthopedic implant sales for the quarter. BY EDITOR, JULY 21, 2003

That's a 26% year-over-year rate of revenue growth. On a constant currency basis, the growth rate was 19%. To put this in context, for all of 2003, Stryker's orthopedic revenue growth was 18%, on a constant currency basis 17%. For... more

It's going to be a great Quarter, Year and Decade BY EDITOR, JULY 14, 2003

Despite being asked by the Merrill analyst to comment on the prospects for the Next Gen product (manufactured by Zimmer... oops, she meant Next Generation), Biomet's CEO, Dane Miller, was his usual wry self as he announced that overall sales... more

Smith and Nephew's Oxinium technology driving 70% year-over-year sales jump BY EDITOR, JUNE 23, 2003

Smith and Nephew's large joint recon business is a muscular enterprise. In its preview of the first half, SNN's management reported that orthopedic revenues are expected to rise 15% year-over-year (YOY), with knees leading the way at a 22% growth... more

Merrill turns bearish on Orthopedics while Stephens puts its money into a sparkling Gem of a spine center. Guess who we think is the smarter investor! BY EDITOR, APRIL 7, 2003

Merrill Lynch's ratings downgrade of, in effect, the entire Orthopedics industry will rank, we think, with Business Week's infamous "Death of Equities" cover story - which coincided with the beginning of the greatest bull market in history - as one... more

Complete Archive